id	sid	tid	token	lemma	pos
bam-7594	1	1	antibiotic	antibiotic	ADJ
bam-7594	1	2	resistance	resistance	NOUN
bam-7594	1	3	of	of	ADP
bam-7594	1	4	nosocomial	nosocomial	ADJ
bam-7594	1	5	infections	infection	NOUN
bam-7594	1	6	eur	eur	PROPN
bam-7594	1	7	j	j	PROPN
bam-7594	1	8	transl	transl	PROPN
bam-7594	1	9	myol	myol	ADV
bam-7594	1	10	28	28	NUM
bam-7594	1	11	(	(	PUNCT
bam-7594	1	12	3	3	NUM
bam-7594	1	13	):	):	PUNCT
bam-7594	1	14	304	304	NUM
bam-7594	1	15	-	-	SYM
bam-7594	1	16	308	308	NUM
bam-7594	1	17	,	,	PUNCT
bam-7594	1	18	2018	2018	NUM
bam-7594	1	19	304	304	NUM
bam-7594	1	20	antibiotic	antibiotic	ADJ
bam-7594	1	21	resistance	resistance	NOUN
bam-7594	1	22	in	in	ADP
bam-7594	1	23	patients	patient	NOUN
bam-7594	1	24	suffering	suffer	VERB
bam-7594	1	25	from	from	ADP
bam-7594	1	26	nosocomial	nosocomial	ADJ
bam-7594	1	27	infections	infection	NOUN
bam-7594	1	28	in	in	ADP
bam-7594	1	29	besat	besat	PROPN
bam-7594	1	30	hospital	hospital	PROPN
bam-7594	1	31	sirous	sirous	ADJ
bam-7594	1	32	faraji	faraji	NOUN
bam-7594	1	33	hormozi	hormozi	NOUN
bam-7594	1	34	(	(	PUNCT
bam-7594	1	35	1	1	NUM
bam-7594	1	36	)	)	PUNCT
bam-7594	1	37	,	,	PUNCT
bam-7594	1	38	narges	narge	NOUN
bam-7594	1	39	vasei	vasei	ADJ
bam-7594	1	40	(	(	PUNCT
bam-7594	1	41	2	2	NUM
bam-7594	1	42	)	)	PUNCT
bam-7594	1	43	,	,	PUNCT
bam-7594	1	44	mohammad	mohammad	PROPN
bam-7594	1	45	aminianfar	aminianfar	ADV
bam-7594	1	46	(	(	PUNCT
bam-7594	1	47	3	3	NUM
bam-7594	1	48	)	)	PUNCT
bam-7594	1	49	,	,	PUNCT
bam-7594	1	50	mohammad	mohammad	PROPN
bam-7594	1	51	darvishi	darvishi	PROPN
bam-7594	1	52	(	(	PUNCT
bam-7594	1	53	3	3	NUM
bam-7594	1	54	)	)	PUNCT
bam-7594	1	55	,	,	PUNCT
bam-7594	1	56	ali	ali	PROPN
bam-7594	1	57	asghar	asghar	PROPN
bam-7594	1	58	saeedi	saeedi	PROPN
bam-7594	1	59	(	(	PUNCT
bam-7594	1	60	1	1	NUM
bam-7594	1	61	)	)	PUNCT
bam-7594	1	62	(	(	PUNCT
bam-7594	1	63	1	1	X
bam-7594	1	64	)	)	PUNCT
bam-7594	1	65	infectious	infectious	ADJ
bam-7594	1	66	diseases	disease	NOUN
bam-7594	1	67	and	and	CCONJ
bam-7594	1	68	tropical	tropical	ADJ
bam-7594	1	69	medicine	medicine	NOUN
bam-7594	1	70	research	research	NOUN
bam-7594	1	71	center	center	NOUN
bam-7594	1	72	(	(	PUNCT
bam-7594	1	73	idtmrc	idtmrc	NOUN
bam-7594	1	74	)	)	PUNCT
bam-7594	1	75	,	,	PUNCT
bam-7594	1	76	aja	aja	PROPN
bam-7594	1	77	university	university	PROPN
bam-7594	1	78	of	of	ADP
bam-7594	1	79	medical	medical	ADJ
bam-7594	1	80	sciences	sciences	PROPN
bam-7594	1	81	,	,	PUNCT
bam-7594	1	82	tehran	tehran	PROPN
bam-7594	1	83	,	,	PUNCT
bam-7594	1	84	iran	iran	PROPN
bam-7594	1	85	;	;	PUNCT
bam-7594	1	86	(	(	PUNCT
bam-7594	1	87	2	2	X
bam-7594	1	88	)	)	PUNCT
bam-7594	1	89	department	department	NOUN
bam-7594	1	90	of	of	ADP
bam-7594	1	91	surgery	surgery	NOUN
bam-7594	1	92	,	,	PUNCT
bam-7594	1	93	besat	besat	NOUN
bam-7594	1	94	hospital	hospital	PROPN
bam-7594	1	95	,	,	PUNCT
bam-7594	1	96	aja	aja	PROPN
bam-7594	1	97	university	university	PROPN
bam-7594	1	98	of	of	ADP
bam-7594	1	99	medical	medical	ADJ
bam-7594	1	100	sciences	sciences	PROPN
bam-7594	1	101	,	,	PUNCT
bam-7594	1	102	tehran	tehran	PROPN
bam-7594	1	103	,	,	PUNCT
bam-7594	1	104	iran	iran	PROPN
bam-7594	1	105	;	;	PUNCT
bam-7594	1	106	(	(	PUNCT
bam-7594	1	107	3	3	X
bam-7594	1	108	)	)	PUNCT
bam-7594	1	109	infectious	infectious	ADJ
bam-7594	1	110	diseases	disease	NOUN
bam-7594	1	111	and	and	CCONJ
bam-7594	1	112	tropical	tropical	ADJ
bam-7594	1	113	medicine	medicine	NOUN
bam-7594	1	114	research	research	NOUN
bam-7594	1	115	center	center	NOUN
bam-7594	1	116	(	(	PUNCT
bam-7594	1	117	idtmrc	idtmrc	NOUN
bam-7594	1	118	)	)	PUNCT
bam-7594	1	119	,	,	PUNCT
bam-7594	1	120	department	department	NOUN
bam-7594	1	121	of	of	ADP
bam-7594	1	122	aerospace	aerospace	NOUN
bam-7594	1	123	and	and	CCONJ
bam-7594	1	124	subaquatic	subaquatic	ADJ
bam-7594	1	125	medicine	medicine	NOUN
bam-7594	1	126	,	,	PUNCT
bam-7594	1	127	aja	aja	PROPN
bam-7594	1	128	university	university	PROPN
bam-7594	1	129	of	of	ADP
bam-7594	1	130	medical	medical	ADJ
bam-7594	1	131	sciences	sciences	PROPN
bam-7594	1	132	,	,	PUNCT
bam-7594	1	133	tehran	tehran	PROPN
bam-7594	1	134	,	,	PUNCT
bam-7594	1	135	iran	iran	PROPN
bam-7594	1	136	this	this	DET
bam-7594	1	137	article	article	NOUN
bam-7594	1	138	is	be	AUX
bam-7594	1	139	distributed	distribute	VERB
bam-7594	1	140	under	under	ADP
bam-7594	1	141	the	the	DET
bam-7594	1	142	terms	term	NOUN
bam-7594	1	143	of	of	ADP
bam-7594	1	144	the	the	DET
bam-7594	1	145	creative	creative	ADJ
bam-7594	1	146	commons	common	NOUN
bam-7594	1	147	attribution	attribution	NOUN
bam-7594	1	148	noncommercial	noncommercial	ADJ
bam-7594	1	149	license	license	NOUN
bam-7594	1	150	(	(	PUNCT
bam-7594	1	151	cc	cc	NOUN
bam-7594	1	152	by	by	ADP
bam-7594	1	153	-	-	PUNCT
bam-7594	1	154	nc	nc	PROPN
bam-7594	1	155	4.0	4.0	NUM
bam-7594	1	156	)	)	PUNCT
bam-7594	1	157	which	which	PRON
bam-7594	1	158	permits	permit	VERB
bam-7594	1	159	any	any	DET
bam-7594	1	160	noncommercial	noncommercial	ADJ
bam-7594	1	161	use	use	NOUN
bam-7594	1	162	,	,	PUNCT
bam-7594	1	163	distribution	distribution	NOUN
bam-7594	1	164	,	,	PUNCT
bam-7594	1	165	and	and	CCONJ
bam-7594	1	166	reproduction	reproduction	NOUN
bam-7594	1	167	in	in	ADP
bam-7594	1	168	any	any	DET
bam-7594	1	169	medium	medium	NOUN
bam-7594	1	170	,	,	PUNCT
bam-7594	1	171	provided	provide	VERB
bam-7594	1	172	the	the	DET
bam-7594	1	173	original	original	ADJ
bam-7594	1	174	author(s	author(s	NOUN
bam-7594	1	175	)	)	PUNCT
bam-7594	1	176	and	and	CCONJ
bam-7594	1	177	source	source	NOUN
bam-7594	1	178	are	be	AUX
bam-7594	1	179	credited	credit	VERB
bam-7594	1	180	.	.	PUNCT
bam-7594	2	1	abstract	abstract	ADJ
bam-7594	2	2	this	this	DET
bam-7594	2	3	study	study	NOUN
bam-7594	2	4	was	be	AUX
bam-7594	2	5	performed	perform	VERB
bam-7594	2	6	to	to	PART
bam-7594	2	7	determine	determine	VERB
bam-7594	2	8	the	the	DET
bam-7594	2	9	trend	trend	NOUN
bam-7594	2	10	of	of	ADP
bam-7594	2	11	antibiotic	antibiotic	ADJ
bam-7594	2	12	resistance	resistance	NOUN
bam-7594	2	13	of	of	ADP
bam-7594	2	14	the	the	DET
bam-7594	2	15	causative	causative	ADJ
bam-7594	2	16	organisms	organism	NOUN
bam-7594	2	17	among	among	ADP
bam-7594	2	18	the	the	DET
bam-7594	2	19	patients	patient	NOUN
bam-7594	2	20	suffering	suffer	VERB
bam-7594	2	21	from	from	ADP
bam-7594	2	22	nosocomial	nosocomial	ADJ
bam-7594	2	23	infections	infection	NOUN
bam-7594	2	24	in	in	ADP
bam-7594	2	25	besat	besat	PROPN
bam-7594	2	26	hospital	hospital	NOUN
bam-7594	2	27	since	since	SCONJ
bam-7594	2	28	2013	2013	NUM
bam-7594	2	29	to	to	ADP
bam-7594	2	30	2015	2015	NUM
bam-7594	2	31	.	.	PUNCT
bam-7594	3	1	in	in	ADP
bam-7594	3	2	this	this	DET
bam-7594	3	3	observational	observational	ADJ
bam-7594	3	4	study	study	NOUN
bam-7594	3	5	that	that	PRON
bam-7594	3	6	was	be	AUX
bam-7594	3	7	performed	perform	VERB
bam-7594	3	8	as	as	ADP
bam-7594	3	9	a	a	DET
bam-7594	3	10	retrospective	retrospective	ADJ
bam-7594	3	11	cohort	cohort	NOUN
bam-7594	3	12	,	,	PUNCT
bam-7594	3	13	935	935	NUM
bam-7594	3	14	consecutive	consecutive	ADJ
bam-7594	3	15	patients	patient	NOUN
bam-7594	3	16	with	with	ADP
bam-7594	3	17	nosocomial	nosocomial	ADJ
bam-7594	3	18	infection	infection	NOUN
bam-7594	3	19	were	be	AUX
bam-7594	3	20	enrolled	enrol	VERB
bam-7594	3	21	in	in	ADP
bam-7594	3	22	besat	besat	PROPN
bam-7594	3	23	hospital	hospital	NOUN
bam-7594	3	24	since	since	SCONJ
bam-7594	3	25	2013	2013	NUM
bam-7594	3	26	to	to	ADP
bam-7594	3	27	2015	2015	NUM
bam-7594	3	28	.	.	PUNCT
bam-7594	4	1	the	the	DET
bam-7594	4	2	trend	trend	NOUN
bam-7594	4	3	of	of	ADP
bam-7594	4	4	antibiotic	antibiotic	ADJ
bam-7594	4	5	resistance	resistance	NOUN
bam-7594	4	6	of	of	ADP
bam-7594	4	7	the	the	DET
bam-7594	4	8	causative	causative	ADJ
bam-7594	4	9	organisms	organism	NOUN
bam-7594	4	10	among	among	ADP
bam-7594	4	11	them	they	PRON
bam-7594	4	12	was	be	AUX
bam-7594	4	13	determined	determine	VERB
bam-7594	4	14	and	and	CCONJ
bam-7594	4	15	contributing	contribute	VERB
bam-7594	4	16	factors	factor	NOUN
bam-7594	4	17	were	be	AUX
bam-7594	4	18	assessed	assess	VERB
bam-7594	4	19	.	.	PUNCT
bam-7594	5	1	the	the	DET
bam-7594	5	2	finding	finding	NOUN
bam-7594	5	3	of	of	ADP
bam-7594	5	4	this	this	DET
bam-7594	5	5	study	study	NOUN
bam-7594	5	6	revealed	reveal	VERB
bam-7594	5	7	that	that	SCONJ
bam-7594	5	8	type	type	NOUN
bam-7594	5	9	of	of	ADP
bam-7594	5	10	microorganisms	microorganism	NOUN
bam-7594	5	11	had	have	VERB
bam-7594	5	12	significant	significant	ADJ
bam-7594	5	13	variation	variation	NOUN
bam-7594	5	14	(	(	PUNCT
bam-7594	5	15	p	p	X
bam-7594	5	16	=	=	NOUN
bam-7594	5	17	0.024	0.024	NUM
bam-7594	5	18	):	):	PUNCT
bam-7594	5	19	while	while	SCONJ
bam-7594	5	20	the	the	DET
bam-7594	5	21	gram	gram	NOUN
bam-7594	5	22	-	-	PUNCT
bam-7594	5	23	negative	negative	ADJ
bam-7594	5	24	bacilli	bacilli	NOUN
bam-7594	5	25	have	have	AUX
bam-7594	5	26	shown	show	VERB
bam-7594	5	27	an	an	DET
bam-7594	5	28	increased	increase	VERB
bam-7594	5	29	level	level	NOUN
bam-7594	5	30	of	of	ADP
bam-7594	5	31	resistance	resistance	NOUN
bam-7594	5	32	,	,	PUNCT
bam-7594	5	33	the	the	DET
bam-7594	5	34	gram	gram	PROPN
bam-7594	5	35	positive	positive	ADJ
bam-7594	5	36	cocci	cocci	NOUN
bam-7594	5	37	had	have	VERB
bam-7594	5	38	less	less	ADJ
bam-7594	5	39	resistance	resistance	NOUN
bam-7594	5	40	.	.	PUNCT
bam-7594	6	1	the	the	DET
bam-7594	6	2	antibiotic	antibiotic	ADJ
bam-7594	6	3	resistance	resistance	NOUN
bam-7594	6	4	was	be	AUX
bam-7594	6	5	increased	increase	VERB
bam-7594	6	6	for	for	ADP
bam-7594	6	7	ampicillin	ampicillin	NOUN
bam-7594	6	8	/	/	SYM
bam-7594	6	9	sulbactam	sulbactam	NOUN
bam-7594	6	10	,	,	PUNCT
bam-7594	6	11	piperacillin	piperacillin	NOUN
bam-7594	6	12	/	/	SYM
bam-7594	6	13	tazoactam	tazoactam	PROPN
bam-7594	6	14	,	,	PUNCT
bam-7594	6	15	ceftriaxone	ceftriaxone	PROPN
bam-7594	6	16	,	,	PUNCT
bam-7594	6	17	ceftazidime	ceftazidime	NOUN
bam-7594	6	18	,	,	PUNCT
bam-7594	6	19	cefepime	cefepime	ADV
bam-7594	6	20	,	,	PUNCT
bam-7594	6	21	meropenem	meropenem	PROPN
bam-7594	6	22	,	,	PUNCT
bam-7594	6	23	gentamicin	gentamicin	NOUN
bam-7594	6	24	,	,	PUNCT
bam-7594	6	25	amikacin	amikacin	PROPN
bam-7594	6	26	,	,	PUNCT
bam-7594	6	27	ciprofloxacine	ciprofloxacine	ADJ
bam-7594	6	28	,	,	PUNCT
bam-7594	6	29	levofloxacine	levofloxacine	NOUN
bam-7594	6	30	,	,	PUNCT
bam-7594	6	31	nitrofurantoin	nitrofurantoin	NOUN
bam-7594	6	32	,	,	PUNCT
bam-7594	6	33	and	and	CCONJ
bam-7594	6	34	ampicilline	ampicilline	NOUN
bam-7594	6	35	.	.	PUNCT
bam-7594	7	1	however	however	ADV
bam-7594	7	2	,	,	PUNCT
bam-7594	7	3	it	it	PRON
bam-7594	7	4	was	be	AUX
bam-7594	7	5	decreased	decrease	VERB
bam-7594	7	6	for	for	ADP
bam-7594	7	7	colistin	colistin	NOUN
bam-7594	7	8	.	.	PUNCT
bam-7594	8	1	in	in	ADP
bam-7594	8	2	conclusion	conclusion	NOUN
bam-7594	8	3	,	,	PUNCT
bam-7594	8	4	antibiotic	antibiotic	ADJ
bam-7594	8	5	resistance	resistance	NOUN
bam-7594	8	6	has	have	VERB
bam-7594	8	7	an	an	DET
bam-7594	8	8	increasing	increase	VERB
bam-7594	8	9	trend	trend	NOUN
bam-7594	8	10	and	and	CCONJ
bam-7594	8	11	strategic	strategic	ADJ
bam-7594	8	12	measures	measure	NOUN
bam-7594	8	13	of	of	ADP
bam-7594	8	14	prevention	prevention	NOUN
bam-7594	8	15	are	be	AUX
bam-7594	8	16	needed	need	VERB
bam-7594	8	17	to	to	PART
bam-7594	8	18	reduce	reduce	VERB
bam-7594	8	19	nosocomial	nosocomial	ADJ
bam-7594	8	20	infections	infection	NOUN
bam-7594	8	21	.	.	PUNCT
bam-7594	9	1	key	key	ADJ
bam-7594	9	2	words	word	NOUN
bam-7594	9	3	:	:	PUNCT
bam-7594	9	4	antibiotic	antibiotic	ADJ
bam-7594	9	5	resistance	resistance	NOUN
bam-7594	9	6	,	,	PUNCT
bam-7594	9	7	trend	trend	NOUN
bam-7594	9	8	,	,	PUNCT
bam-7594	9	9	nosocomial	nosocomial	ADJ
bam-7594	9	10	infection	infection	NOUN
bam-7594	9	11	,	,	PUNCT
bam-7594	9	12	health	health	NOUN
bam-7594	9	13	care	care	PROPN
bam-7594	9	14	eur	eur	PROPN
bam-7594	9	15	j	j	PROPN
bam-7594	9	16	transl	transl	PROPN
bam-7594	9	17	myol	myol	ADV
bam-7594	9	18	28	28	NUM
bam-7594	9	19	(	(	PUNCT
bam-7594	9	20	3	3	NUM
bam-7594	9	21	):	):	PUNCT
bam-7594	9	22	304	304	NUM
bam-7594	9	23	-	-	SYM
bam-7594	9	24	308	308	NUM
bam-7594	9	25	,	,	PUNCT
bam-7594	9	26	2018	2018	NUM
bam-7594	9	27	hospital	hospital	NOUN
bam-7594	9	28	infections	infection	NOUN
bam-7594	9	29	and	and	CCONJ
bam-7594	9	30	antibiotic	antibiotic	ADJ
bam-7594	9	31	resistance	resistance	NOUN
bam-7594	9	32	are	be	AUX
bam-7594	9	33	problems	problem	NOUN
bam-7594	9	34	that	that	PRON
bam-7594	9	35	have	have	AUX
bam-7594	9	36	been	be	AUX
bam-7594	9	37	reported	report	VERB
bam-7594	9	38	for	for	ADP
bam-7594	9	39	many	many	ADJ
bam-7594	9	40	years	year	NOUN
bam-7594	9	41	around	around	ADP
bam-7594	9	42	the	the	DET
bam-7594	9	43	world	world	NOUN
bam-7594	9	44	,	,	PUNCT
bam-7594	9	45	causing	cause	VERB
bam-7594	9	46	the	the	DET
bam-7594	9	47	monetary	monetary	ADJ
bam-7594	9	48	burden	burden	NOUN
bam-7594	9	49	and	and	CCONJ
bam-7594	9	50	prolonged	prolonged	ADJ
bam-7594	9	51	treatment	treatment	NOUN
bam-7594	9	52	.	.	PUNCT
bam-7594	10	1	an	an	DET
bam-7594	10	2	epidemiological	epidemiological	ADJ
bam-7594	10	3	study	study	NOUN
bam-7594	10	4	on	on	ADP
bam-7594	10	5	the	the	DET
bam-7594	10	6	incidence	incidence	NOUN
bam-7594	10	7	of	of	ADP
bam-7594	10	8	hospital	hospital	NOUN
bam-7594	10	9	infections	infection	NOUN
bam-7594	10	10	in	in	ADP
bam-7594	10	11	the	the	DET
bam-7594	10	12	united	united	PROPN
bam-7594	10	13	states	states	PROPN
bam-7594	10	14	showed	show	VERB
bam-7594	10	15	that	that	SCONJ
bam-7594	10	16	,	,	PUNCT
bam-7594	10	17	the	the	DET
bam-7594	10	18	risk	risk	NOUN
bam-7594	10	19	of	of	ADP
bam-7594	10	20	infectious	infectious	ADJ
bam-7594	10	21	diseases	disease	NOUN
bam-7594	10	22	has	have	AUX
bam-7594	10	23	increased	increase	VERB
bam-7594	10	24	steadily	steadily	ADV
bam-7594	10	25	.	.	PUNCT
bam-7594	11	1	a	a	DET
bam-7594	11	2	total	total	NOUN
bam-7594	11	3	of	of	ADP
bam-7594	11	4	2	2	NUM
bam-7594	11	5	million	million	NUM
bam-7594	11	6	people	people	NOUN
bam-7594	11	7	are	be	AUX
bam-7594	11	8	affected	affect	VERB
bam-7594	11	9	by	by	ADP
bam-7594	11	10	a	a	DET
bam-7594	11	11	hospital	hospital	NOUN
bam-7594	11	12	infection	infection	NOUN
bam-7594	11	13	,	,	PUNCT
bam-7594	11	14	where	where	SCONJ
bam-7594	11	15	it	it	PRON
bam-7594	11	16	is	be	AUX
bam-7594	11	17	being	be	AUX
bam-7594	11	18	imposed	impose	VERB
bam-7594	11	19	on	on	ADP
bam-7594	11	20	the	the	DET
bam-7594	11	21	health	health	NOUN
bam-7594	11	22	system	system	NOUN
bam-7594	11	23	at	at	ADP
bam-7594	11	24	a	a	DET
bam-7594	11	25	cost	cost	NOUN
bam-7594	11	26	of	of	ADP
bam-7594	11	27	$	$	SYM
bam-7594	11	28	4.5	4.5	NUM
bam-7594	11	29	to	to	PART
bam-7594	11	30	$	$	SYM
bam-7594	11	31	11	11	NUM
bam-7594	11	32	billion	billion	NUM
bam-7594	11	33	.	.	PUNCT
bam-7594	12	1	in	in	ADP
bam-7594	12	2	addition	addition	NOUN
bam-7594	12	3	,	,	PUNCT
bam-7594	12	4	80,000	80,000	NUM
bam-7594	12	5	deaths	death	NOUN
bam-7594	12	6	annually	annually	ADV
bam-7594	12	7	occur	occur	VERB
bam-7594	12	8	due	due	ADP
bam-7594	12	9	to	to	ADP
bam-7594	12	10	hospital	hospital	NOUN
bam-7594	12	11	infections.1	infections.1	PROPN
bam-7594	12	12	hospital	hospital	NOUN
bam-7594	12	13	infections	infection	NOUN
bam-7594	12	14	are	be	AUX
bam-7594	12	15	caused	cause	VERB
bam-7594	12	16	by	by	ADP
bam-7594	12	17	hospitalization	hospitalization	NOUN
bam-7594	12	18	48	48	NUM
bam-7594	12	19	hours	hour	NOUN
bam-7594	12	20	after	after	ADP
bam-7594	12	21	the	the	DET
bam-7594	12	22	patient	patient	ADJ
bam-7594	12	23	admission	admission	NOUN
bam-7594	12	24	or	or	CCONJ
bam-7594	12	25	30	30	NUM
bam-7594	12	26	days	day	NOUN
bam-7594	12	27	after	after	ADP
bam-7594	12	28	being	be	AUX
bam-7594	12	29	discharged	discharge	VERB
bam-7594	12	30	from	from	ADP
bam-7594	12	31	the	the	DET
bam-7594	12	32	hospital	hospital	NOUN
bam-7594	12	33	.	.	PUNCT
bam-7594	13	1	nosocomial	nosocomial	ADJ
bam-7594	13	2	infections	infection	NOUN
bam-7594	13	3	are	be	AUX
bam-7594	13	4	one	one	NUM
bam-7594	13	5	of	of	ADP
bam-7594	13	6	the	the	DET
bam-7594	13	7	most	most	ADV
bam-7594	13	8	common	common	ADJ
bam-7594	13	9	types	type	NOUN
bam-7594	13	10	of	of	ADP
bam-7594	13	11	infections.2	infections.2	NOUN
bam-7594	13	12	these	these	DET
bam-7594	13	13	infections	infection	NOUN
bam-7594	13	14	are	be	AUX
bam-7594	13	15	mainly	mainly	ADV
bam-7594	13	16	caused	cause	VERB
bam-7594	13	17	by	by	ADP
bam-7594	13	18	bacterial	bacterial	ADJ
bam-7594	13	19	agents	agent	NOUN
bam-7594	13	20	,	,	PUNCT
bam-7594	13	21	such	such	ADJ
bam-7594	13	22	as	as	ADP
bam-7594	13	23	staphylococcus	staphylococcus	NOUN
bam-7594	13	24	,	,	PUNCT
bam-7594	13	25	pseudomonas	pseudomona	NOUN
bam-7594	13	26	and	and	CCONJ
bam-7594	13	27	escherichia	escherichia	NOUN
bam-7594	13	28	coli	coli	NOUN
bam-7594	13	29	,	,	PUNCT
bam-7594	13	30	and	and	CCONJ
bam-7594	13	31	are	be	AUX
bam-7594	13	32	more	more	ADV
bam-7594	13	33	often	often	ADV
bam-7594	13	34	observed	observe	VERB
bam-7594	13	35	as	as	ADP
bam-7594	13	36	pneumonia	pneumonia	NOUN
bam-7594	13	37	and	and	CCONJ
bam-7594	13	38	urinary	urinary	ADJ
bam-7594	13	39	tract	tract	NOUN
bam-7594	13	40	infections	infection	NOUN
bam-7594	13	41	(	(	PUNCT
bam-7594	13	42	uti	uti	PROPN
bam-7594	13	43	)	)	PUNCT
bam-7594	13	44	,	,	PUNCT
bam-7594	13	45	in	in	ADP
bam-7594	13	46	22	22	NUM
bam-7594	13	47	patients	patient	NOUN
bam-7594	13	48	per	per	ADP
bam-7594	13	49	1,000	1,000	NUM
bam-7594	13	50	people.2	people.2	NOUN
bam-7594	13	51	however	however	ADV
bam-7594	13	52	,	,	PUNCT
bam-7594	13	53	the	the	DET
bam-7594	13	54	main	main	ADJ
bam-7594	13	55	cause	cause	NOUN
bam-7594	13	56	of	of	ADP
bam-7594	13	57	infection	infection	NOUN
bam-7594	13	58	is	be	AUX
bam-7594	13	59	not	not	PART
bam-7594	13	60	detected	detect	VERB
bam-7594	13	61	in	in	ADP
bam-7594	13	62	17	17	NUM
bam-7594	13	63	%	%	NOUN
bam-7594	13	64	of	of	ADP
bam-7594	13	65	patients.2	patients.2	PROPN
bam-7594	13	66	it	it	PRON
bam-7594	13	67	is	be	AUX
bam-7594	13	68	worth	worth	ADJ
bam-7594	13	69	noting	note	VERB
bam-7594	13	70	that	that	SCONJ
bam-7594	13	71	staphylococcus	staphylococcus	NOUN
bam-7594	13	72	aureus	aureus	NOUN
bam-7594	13	73	is	be	AUX
bam-7594	13	74	the	the	DET
bam-7594	13	75	most	most	ADV
bam-7594	13	76	common	common	ADJ
bam-7594	13	77	form	form	NOUN
bam-7594	13	78	of	of	ADP
bam-7594	13	79	pneumonia	pneumonia	NOUN
bam-7594	13	80	and	and	CCONJ
bam-7594	13	81	escherichia	escherichia	NOUN
bam-7594	13	82	coli	coli	NOUN
bam-7594	13	83	in	in	ADP
bam-7594	13	84	cases	case	NOUN
bam-7594	13	85	of	of	ADP
bam-7594	13	86	uti.3	uti.3	NOUN
bam-7594	13	87	of	of	ADP
bam-7594	13	88	course	course	NOUN
bam-7594	13	89	,	,	PUNCT
bam-7594	13	90	the	the	DET
bam-7594	13	91	rates	rate	NOUN
bam-7594	13	92	and	and	CCONJ
bam-7594	13	93	types	type	NOUN
bam-7594	13	94	of	of	ADP
bam-7594	13	95	hospital	hospital	NOUN
bam-7594	13	96	infections	infection	NOUN
bam-7594	13	97	are	be	AUX
bam-7594	13	98	different	different	ADJ
bam-7594	13	99	in	in	ADP
bam-7594	13	100	various	various	ADJ
bam-7594	13	101	hospitals	hospital	NOUN
bam-7594	13	102	,	,	PUNCT
bam-7594	13	103	where	where	SCONJ
bam-7594	13	104	the	the	DET
bam-7594	13	105	rates	rate	NOUN
bam-7594	13	106	of	of	ADP
bam-7594	13	107	uti	uti	PROPN
bam-7594	13	108	,	,	PUNCT
bam-7594	13	109	pneumonia	pneumonia	NOUN
bam-7594	13	110	,	,	PUNCT
bam-7594	13	111	and	and	CCONJ
bam-7594	13	112	bacteremia	bacteremia	NOUN
bam-7594	13	113	are	be	AUX
bam-7594	13	114	the	the	DET
bam-7594	13	115	most	most	ADV
bam-7594	13	116	common	common	ADJ
bam-7594	13	117	types	type	NOUN
bam-7594	13	118	in	in	ADP
bam-7594	13	119	some	some	DET
bam-7594	13	120	hospitals.4	hospitals.4	NOUN
bam-7594	13	121	therefore	therefore	ADV
bam-7594	13	122	,	,	PUNCT
bam-7594	13	123	their	their	PRON
bam-7594	13	124	therapeutic	therapeutic	ADJ
bam-7594	13	125	pattern	pattern	NOUN
bam-7594	13	126	is	be	AUX
bam-7594	13	127	different	different	ADJ
bam-7594	13	128	in	in	ADP
bam-7594	13	129	treatment	treatment	NOUN
bam-7594	13	130	centers	center	NOUN
bam-7594	13	131	where	where	SCONJ
bam-7594	13	132	is	be	AUX
bam-7594	13	133	dominated	dominate	VERB
bam-7594	13	134	by	by	ADP
bam-7594	13	135	predominant	predominant	ADJ
bam-7594	13	136	microorganisms	microorganism	NOUN
bam-7594	13	137	and	and	CCONJ
bam-7594	13	138	resistant	resistant	ADJ
bam-7594	13	139	types	type	NOUN
bam-7594	13	140	.	.	PUNCT
bam-7594	14	1	antibiotic	antibiotic	ADJ
bam-7594	14	2	resistance	resistance	NOUN
bam-7594	14	3	can	can	AUX
bam-7594	14	4	be	be	AUX
bam-7594	14	5	initial	initial	ADJ
bam-7594	14	6	or	or	CCONJ
bam-7594	14	7	acquired	acquire	VERB
bam-7594	14	8	.	.	PUNCT
bam-7594	15	1	resistant	resistant	ADJ
bam-7594	15	2	agents	agent	NOUN
bam-7594	15	3	are	be	AUX
bam-7594	15	4	generally	generally	ADV
bam-7594	15	5	bacteria	bacteria	NOUN
bam-7594	15	6	that	that	PRON
bam-7594	15	7	have	have	VERB
bam-7594	15	8	high	high	ADJ
bam-7594	15	9	virulence	virulence	NOUN
bam-7594	15	10	,	,	PUNCT
bam-7594	15	11	such	such	ADJ
bam-7594	15	12	as	as	ADP
bam-7594	15	13	staphylococcus	staphylococcus	NOUN
bam-7594	15	14	aureus	aureus	NOUN
bam-7594	15	15	.	.	PUNCT
bam-7594	16	1	also	also	ADV
bam-7594	16	2	,	,	PUNCT
bam-7594	16	3	antibiotic	antibiotic	ADJ
bam-7594	16	4	resistance	resistance	NOUN
bam-7594	16	5	is	be	AUX
bam-7594	16	6	related	relate	VERB
bam-7594	16	7	to	to	ADP
bam-7594	16	8	their	their	PRON
bam-7594	16	9	history	history	NOUN
bam-7594	16	10	of	of	ADP
bam-7594	16	11	use	use	NOUN
bam-7594	16	12	.	.	PUNCT
bam-7594	17	1	the	the	DET
bam-7594	17	2	most	most	ADV
bam-7594	17	3	important	important	ADJ
bam-7594	17	4	steps	step	NOUN
bam-7594	17	5	in	in	ADP
bam-7594	17	6	preventing	prevent	VERB
bam-7594	17	7	hospital	hospital	NOUN
bam-7594	17	8	infections	infection	NOUN
bam-7594	17	9	are	be	AUX
bam-7594	17	10	identifying	identify	VERB
bam-7594	17	11	the	the	DET
bam-7594	17	12	factors	factor	NOUN
bam-7594	17	13	that	that	PRON
bam-7594	17	14	affect	affect	VERB
bam-7594	17	15	these	these	DET
bam-7594	17	16	infections	infection	NOUN
bam-7594	17	17	and	and	CCONJ
bam-7594	17	18	taking	take	VERB
bam-7594	17	19	precautionary	precautionary	ADJ
bam-7594	17	20	measures	measure	NOUN
bam-7594	17	21	based	base	VERB
bam-7594	17	22	on	on	ADP
bam-7594	17	23	the	the	DET
bam-7594	17	24	use	use	NOUN
bam-7594	17	25	of	of	ADP
bam-7594	17	26	appropriate	appropriate	ADJ
bam-7594	17	27	strategies.5	strategies.5	NOUN
bam-7594	17	28	in	in	ADP
bam-7594	17	29	this	this	DET
bam-7594	17	30	regard	regard	NOUN
bam-7594	17	31	,	,	PUNCT
bam-7594	17	32	in	in	ADP
bam-7594	17	33	this	this	DET
bam-7594	17	34	regard	regard	NOUN
bam-7594	17	35	,	,	PUNCT
bam-7594	17	36	the	the	DET
bam-7594	17	37	establishment	establishment	NOUN
bam-7594	17	38	of	of	ADP
bam-7594	17	39	surveillance	surveillance	NOUN
bam-7594	17	40	systems	system	NOUN
bam-7594	17	41	is	be	AUX
bam-7594	17	42	important	important	ADJ
bam-7594	17	43	to	to	PART
bam-7594	17	44	track	track	VERB
bam-7594	17	45	the	the	DET
bam-7594	17	46	trend	trend	NOUN
bam-7594	17	47	of	of	ADP
bam-7594	17	48	hospital	hospital	NOUN
bam-7594	17	49	infections	infection	NOUN
bam-7594	17	50	6	6	NUM
bam-7594	17	51	.	.	PUNCT
bam-7594	18	1	the	the	DET
bam-7594	18	2	importance	importance	NOUN
bam-7594	18	3	and	and	CCONJ
bam-7594	18	4	necessity	necessity	NOUN
bam-7594	18	5	of	of	ADP
bam-7594	18	6	this	this	PRON
bam-7594	18	7	is	be	AUX
bam-7594	18	8	especially	especially	ADV
bam-7594	18	9	more	more	ADJ
bam-7594	18	10	for	for	ADP
bam-7594	18	11	antibiotic	antibiotic	ADJ
bam-7594	18	12	resistance	resistance	NOUN
bam-7594	18	13	because	because	SCONJ
bam-7594	18	14	,	,	PUNCT
bam-7594	18	15	according	accord	VERB
bam-7594	18	16	to	to	ADP
bam-7594	18	17	available	available	ADJ
bam-7594	18	18	reports	report	NOUN
bam-7594	18	19	,	,	PUNCT
bam-7594	18	20	this	this	PRON
bam-7594	18	21	non	non	PROPN
bam-7594	18	22	co	co	PROPN
bam-7594	18	23	mmerc	mmerc	PROPN
bam-7594	18	24	ial	ial	PROPN
bam-7594	18	25	us	us	PROPN
bam-7594	18	26	e	e	NOUN
bam-7594	18	27	o	o	NOUN
bam-7594	18	28	nly	nly	ADV
bam-7594	18	29	antibiotic	antibiotic	ADJ
bam-7594	18	30	resistance	resistance	NOUN
bam-7594	18	31	of	of	ADP
bam-7594	18	32	nosocomial	nosocomial	ADJ
bam-7594	18	33	infections	infection	NOUN
bam-7594	18	34	eur	eur	PROPN
bam-7594	18	35	j	j	PROPN
bam-7594	18	36	transl	transl	PROPN
bam-7594	18	37	myol	myol	ADV
bam-7594	18	38	28	28	NUM
bam-7594	18	39	(	(	PUNCT
bam-7594	18	40	3	3	NUM
bam-7594	18	41	):	):	PUNCT
bam-7594	18	42	304	304	NUM
bam-7594	18	43	-	-	SYM
bam-7594	18	44	308	308	NUM
bam-7594	18	45	,	,	PUNCT
bam-7594	18	46	2018	2018	NUM
bam-7594	18	47	305	305	NUM
bam-7594	18	48	issue	issue	NOUN
bam-7594	18	49	is	be	AUX
bam-7594	18	50	rising	rise	VERB
bam-7594	18	51	.	.	PUNCT
bam-7594	19	1	by	by	ADP
bam-7594	19	2	identifying	identify	VERB
bam-7594	19	3	the	the	DET
bam-7594	19	4	pattern	pattern	NOUN
bam-7594	19	5	of	of	ADP
bam-7594	19	6	antibiotic	antibiotic	ADJ
bam-7594	19	7	resistance	resistance	NOUN
bam-7594	19	8	changes	change	NOUN
bam-7594	19	9	,	,	PUNCT
bam-7594	19	10	it	it	PRON
bam-7594	19	11	is	be	AUX
bam-7594	19	12	possible	possible	ADJ
bam-7594	19	13	to	to	PART
bam-7594	19	14	provide	provide	VERB
bam-7594	19	15	suggestions	suggestion	NOUN
bam-7594	19	16	on	on	ADP
bam-7594	19	17	how	how	SCONJ
bam-7594	19	18	antibiotics	antibiotic	NOUN
bam-7594	19	19	are	be	AUX
bam-7594	19	20	administered	administer	VERB
bam-7594	19	21	,	,	PUNCT
bam-7594	19	22	and	and	CCONJ
bam-7594	19	23	how	how	SCONJ
bam-7594	19	24	to	to	PART
bam-7594	19	25	change	change	VERB
bam-7594	19	26	their	their	PRON
bam-7594	19	27	course	course	NOUN
bam-7594	19	28	,	,	PUNCT
bam-7594	19	29	as	as	ADV
bam-7594	19	30	well	well	ADV
bam-7594	19	31	as	as	ADP
bam-7594	19	32	empirical	empirical	ADJ
bam-7594	19	33	treatment	treatment	NOUN
bam-7594	19	34	.	.	PUNCT
bam-7594	20	1	therefore	therefore	ADV
bam-7594	20	2	,	,	PUNCT
bam-7594	20	3	the	the	DET
bam-7594	20	4	present	present	ADJ
bam-7594	20	5	study	study	NOUN
bam-7594	20	6	was	be	AUX
bam-7594	20	7	aimed	aim	VERB
bam-7594	20	8	to	to	PART
bam-7594	20	9	investigate	investigate	VERB
bam-7594	20	10	the	the	DET
bam-7594	20	11	change	change	NOUN
bam-7594	20	12	in	in	ADP
bam-7594	20	13	the	the	DET
bam-7594	20	14	pattern	pattern	NOUN
bam-7594	20	15	of	of	ADP
bam-7594	20	16	antibiotic	antibiotic	ADJ
bam-7594	20	17	resistance	resistance	NOUN
bam-7594	20	18	in	in	ADP
bam-7594	20	19	the	the	DET
bam-7594	20	20	microorganisms	microorganism	NOUN
bam-7594	20	21	causing	cause	VERB
bam-7594	20	22	nosocomial	nosocomial	ADJ
bam-7594	20	23	infections	infection	NOUN
bam-7594	20	24	during	during	ADP
bam-7594	20	25	the	the	DET
bam-7594	20	26	years	year	NOUN
bam-7594	20	27	2013	2013	NUM
bam-7594	20	28	to	to	ADP
bam-7594	20	29	2015	2015	NUM
bam-7594	20	30	in	in	ADP
bam-7594	20	31	besat	besat	PROPN
bam-7594	20	32	hospital	hospital	NOUN
bam-7594	20	33	.	.	PUNCT
bam-7594	21	1	materials	material	NOUN
bam-7594	21	2	and	and	CCONJ
bam-7594	21	3	methods	method	NOUN
bam-7594	21	4	this	this	DET
bam-7594	21	5	observational	observational	ADJ
bam-7594	21	6	study	study	NOUN
bam-7594	21	7	was	be	AUX
bam-7594	21	8	conducted	conduct	VERB
bam-7594	21	9	as	as	ADP
bam-7594	21	10	a	a	DET
bam-7594	21	11	retrospective	retrospective	ADJ
bam-7594	21	12	cohort	cohort	NOUN
bam-7594	21	13	study	study	NOUN
bam-7594	21	14	.	.	PUNCT
bam-7594	22	1	a	a	DET
bam-7594	22	2	total	total	NOUN
bam-7594	22	3	of	of	ADP
bam-7594	22	4	935	935	NUM
bam-7594	22	5	patients	patient	NOUN
bam-7594	22	6	with	with	ADP
bam-7594	22	7	nosocomial	nosocomial	ADJ
bam-7594	22	8	infections	infection	NOUN
bam-7594	22	9	during	during	ADP
bam-7594	22	10	the	the	DET
bam-7594	22	11	years	year	NOUN
bam-7594	22	12	92	92	NUM
bam-7594	22	13	to	to	PART
bam-7594	22	14	94	94	NUM
bam-7594	22	15	were	be	AUX
bam-7594	22	16	selected	select	VERB
bam-7594	22	17	and	and	CCONJ
bam-7594	22	18	examined	examine	VERB
bam-7594	22	19	in	in	ADP
bam-7594	22	20	besat	besat	PROPN
bam-7594	22	21	hospital	hospital	NOUN
bam-7594	22	22	.	.	PUNCT
bam-7594	23	1	also	also	ADV
bam-7594	23	2	,	,	PUNCT
bam-7594	23	3	antibiotic	antibiotic	ADJ
bam-7594	23	4	resistance	resistance	NOUN
bam-7594	23	5	patterns	pattern	NOUN
bam-7594	23	6	were	be	AUX
bam-7594	23	7	studied	study	VERB
bam-7594	23	8	in	in	ADP
bam-7594	23	9	microorganisms	microorganism	NOUN
bam-7594	23	10	based	base	VERB
bam-7594	23	11	on	on	ADP
bam-7594	23	12	antibiogram	antibiogram	PROPN
bam-7594	23	13	and	and	CCONJ
bam-7594	23	14	their	their	PRON
bam-7594	23	15	relationship	relationship	NOUN
bam-7594	23	16	with	with	ADP
bam-7594	23	17	other	other	ADJ
bam-7594	23	18	variables	variable	NOUN
bam-7594	23	19	was	be	AUX
bam-7594	23	20	evaluated	evaluate	VERB
bam-7594	23	21	.	.	PUNCT
bam-7594	24	1	data	datum	NOUN
bam-7594	24	2	were	be	AUX
bam-7594	24	3	analyzed	analyze	VERB
bam-7594	24	4	using	use	VERB
bam-7594	24	5	spss	spss	PROPN
bam-7594	24	6	software	software	NOUN
bam-7594	24	7	version	version	NOUN
bam-7594	24	8	13	13	NUM
bam-7594	24	9	.	.	PUNCT
bam-7594	25	1	mean	mean	VERB
bam-7594	25	2	and	and	CCONJ
bam-7594	25	3	standard	standard	ADJ
bam-7594	25	4	deviation	deviation	NOUN
bam-7594	25	5	were	be	AUX
bam-7594	25	6	determined	determine	VERB
bam-7594	25	7	for	for	ADP
bam-7594	25	8	quantitative	quantitative	ADJ
bam-7594	25	9	variables	variable	NOUN
bam-7594	25	10	while	while	SCONJ
bam-7594	25	11	absolute	absolute	ADJ
bam-7594	25	12	and	and	CCONJ
bam-7594	25	13	relative	relative	ADJ
bam-7594	25	14	frequency	frequency	NOUN
bam-7594	25	15	was	be	AUX
bam-7594	25	16	recorded	record	VERB
bam-7594	25	17	for	for	ADP
bam-7594	25	18	qualitative	qualitative	ADJ
bam-7594	25	19	variables	variable	NOUN
bam-7594	25	20	.	.	PUNCT
bam-7594	26	1	chi	chi	ADJ
bam-7594	26	2	-	-	PUNCT
bam-7594	26	3	square	square	PROPN
bam-7594	26	4	,	,	PUNCT
bam-7594	26	5	fisher	fisher	PROPN
bam-7594	26	6	,	,	PUNCT
bam-7594	26	7	t	t	PROPN
bam-7594	26	8	-	-	PUNCT
bam-7594	26	9	independent	independent	PROPN
bam-7594	26	10	and	and	CCONJ
bam-7594	26	11	anova	anova	PROPN
bam-7594	26	12	test	test	NOUN
bam-7594	26	13	were	be	AUX
bam-7594	26	14	used	use	VERB
bam-7594	26	15	to	to	PART
bam-7594	26	16	evaluate	evaluate	VERB
bam-7594	26	17	the	the	DET
bam-7594	26	18	variables	variable	NOUN
bam-7594	26	19	.	.	PUNCT
bam-7594	27	1	a	a	DET
bam-7594	27	2	p	p	NOUN
bam-7594	27	3	value	value	NOUN
bam-7594	27	4	<	<	X
bam-7594	27	5	0.05	0.05	NUM
bam-7594	27	6	was	be	AUX
bam-7594	27	7	considered	consider	VERB
bam-7594	27	8	significant	significant	ADJ
bam-7594	27	9	.	.	PUNCT
bam-7594	28	1	results	result	NOUN
bam-7594	28	2	and	and	CCONJ
bam-7594	28	3	discussion	discussion	NOUN
bam-7594	28	4	in	in	ADP
bam-7594	28	5	the	the	DET
bam-7594	28	6	present	present	ADJ
bam-7594	28	7	study	study	NOUN
bam-7594	28	8	,	,	PUNCT
bam-7594	28	9	a	a	DET
bam-7594	28	10	total	total	NOUN
bam-7594	28	11	of	of	ADP
bam-7594	28	12	935	935	NUM
bam-7594	28	13	patients	patient	NOUN
bam-7594	28	14	with	with	ADP
bam-7594	28	15	nosocomial	nosocomial	ADJ
bam-7594	28	16	infections	infection	NOUN
bam-7594	28	17	were	be	AUX
bam-7594	28	18	evaluated	evaluate	VERB
bam-7594	28	19	,	,	PUNCT
bam-7594	28	20	from	from	ADP
bam-7594	28	21	of	of	ADP
bam-7594	28	22	which	which	PRON
bam-7594	28	23	514	514	NUM
bam-7594	28	24	cases	case	NOUN
bam-7594	28	25	(	(	PUNCT
bam-7594	28	26	55	55	NUM
bam-7594	28	27	%	%	NOUN
bam-7594	28	28	)	)	PUNCT
bam-7594	28	29	were	be	AUX
bam-7594	28	30	male	male	ADJ
bam-7594	28	31	and	and	CCONJ
bam-7594	28	32	421	421	NUM
bam-7594	28	33	(	(	PUNCT
bam-7594	28	34	45	45	NUM
bam-7594	28	35	%	%	NOUN
bam-7594	28	36	)	)	PUNCT
bam-7594	28	37	were	be	AUX
bam-7594	28	38	female	female	ADJ
bam-7594	28	39	.	.	PUNCT
bam-7594	29	1	sex	sex	NOUN
bam-7594	29	2	distribution	distribution	NOUN
bam-7594	29	3	was	be	AUX
bam-7594	29	4	not	not	PART
bam-7594	29	5	statistically	statistically	ADV
bam-7594	29	6	significant	significant	ADJ
bam-7594	29	7	in	in	ADP
bam-7594	29	8	the	the	DET
bam-7594	29	9	studied	studied	ADJ
bam-7594	29	10	years	year	NOUN
bam-7594	29	11	(	(	PUNCT
bam-7594	29	12	p	p	X
bam-7594	29	13	>	>	X
bam-7594	29	14	0.05).the	0.05).the	NOUN
bam-7594	29	15	mean	mean	ADJ
bam-7594	29	16	age	age	NOUN
bam-7594	29	17	of	of	ADP
bam-7594	29	18	patients	patient	NOUN
bam-7594	29	19	in	in	ADP
bam-7594	29	20	studied	studied	ADJ
bam-7594	29	21	years	year	NOUN
bam-7594	29	22	was	be	AUX
bam-7594	29	23	63.9	63.9	NUM
bam-7594	29	24	±	±	NUM
bam-7594	29	25	36.18	36.18	NUM
bam-7594	29	26	to	to	ADP
bam-7594	29	27	66.38	66.38	NUM
bam-7594	29	28	±	±	NOUN
bam-7594	29	29	29.18	29.18	NUM
bam-7594	29	30	years	year	NOUN
bam-7594	29	31	.	.	PUNCT
bam-7594	30	1	the	the	DET
bam-7594	30	2	frequency	frequency	NOUN
bam-7594	30	3	of	of	ADP
bam-7594	30	4	age	age	NOUN
bam-7594	30	5	distribution	distribution	NOUN
bam-7594	30	6	of	of	ADP
bam-7594	30	7	patients	patient	NOUN
bam-7594	30	8	did	do	AUX
bam-7594	30	9	not	not	PART
bam-7594	30	10	show	show	VERB
bam-7594	30	11	a	a	DET
bam-7594	30	12	significant	significant	ADJ
bam-7594	30	13	difference	difference	NOUN
bam-7594	30	14	(	(	PUNCT
bam-7594	30	15	p	p	X
bam-7594	30	16	>	>	X
bam-7594	30	17	0.05	0.05	NUM
bam-7594	30	18	)	)	PUNCT
bam-7594	30	19	.	.	PUNCT
bam-7594	31	1	regarding	regard	VERB
bam-7594	31	2	to	to	ADP
bam-7594	31	3	the	the	DET
bam-7594	31	4	type	type	NOUN
bam-7594	31	5	of	of	ADP
bam-7594	31	6	cultivation	cultivation	NOUN
bam-7594	31	7	,	,	PUNCT
bam-7594	31	8	631	631	NUM
bam-7594	31	9	cases	case	NOUN
bam-7594	31	10	belonged	belong	VERB
bam-7594	31	11	to	to	ADP
bam-7594	31	12	sputum	sputum	PROPN
bam-7594	31	13	culture	culture	NOUN
bam-7594	31	14	(	(	PUNCT
bam-7594	31	15	67.5	67.5	NUM
bam-7594	31	16	%	%	NOUN
bam-7594	31	17	)	)	PUNCT
bam-7594	31	18	,	,	PUNCT
bam-7594	31	19	followed	follow	VERB
bam-7594	31	20	by	by	ADP
bam-7594	31	21	49	49	NUM
bam-7594	31	22	blood	blood	NOUN
bam-7594	31	23	cultures	culture	NOUN
bam-7594	31	24	(	(	PUNCT
bam-7594	31	25	5.2	5.2	NUM
bam-7594	31	26	%	%	NOUN
bam-7594	31	27	)	)	PUNCT
bam-7594	31	28	,	,	PUNCT
bam-7594	31	29	187	187	NUM
bam-7594	31	30	urine	urine	NOUN
bam-7594	31	31	culture	culture	NOUN
bam-7594	31	32	(	(	PUNCT
bam-7594	31	33	20	20	NUM
bam-7594	31	34	%	%	NOUN
bam-7594	31	35	)	)	PUNCT
bam-7594	31	36	,	,	PUNCT
bam-7594	31	37	68	68	NUM
bam-7594	31	38	ulcer	ulcer	NOUN
bam-7594	31	39	culture	culture	NOUN
bam-7594	31	40	(	(	PUNCT
bam-7594	31	41	7.3	7.3	NUM
bam-7594	31	42	%	%	NOUN
bam-7594	31	43	)	)	PUNCT
bam-7594	31	44	.	.	PUNCT
bam-7594	32	1	the	the	DET
bam-7594	32	2	distribution	distribution	NOUN
bam-7594	32	3	of	of	ADP
bam-7594	32	4	the	the	DET
bam-7594	32	5	type	type	NOUN
bam-7594	32	6	of	of	ADP
bam-7594	32	7	patient	patient	ADJ
bam-7594	32	8	sample	sample	NOUN
bam-7594	32	9	did	do	AUX
bam-7594	32	10	not	not	PART
bam-7594	32	11	show	show	VERB
bam-7594	32	12	a	a	DET
bam-7594	32	13	significant	significant	ADJ
bam-7594	32	14	difference	difference	NOUN
bam-7594	32	15	(	(	PUNCT
bam-7594	32	16	p	p	X
bam-7594	32	17	>	>	X
bam-7594	32	18	0.05	0.05	NUM
bam-7594	32	19	)	)	PUNCT
bam-7594	32	20	.	.	PUNCT
bam-7594	33	1	regarding	regard	VERB
bam-7594	33	2	the	the	DET
bam-7594	33	3	frequency	frequency	NOUN
bam-7594	33	4	of	of	ADP
bam-7594	33	5	disease	disease	NOUN
bam-7594	33	6	type	type	NOUN
bam-7594	33	7	,	,	PUNCT
bam-7594	33	8	363	363	NUM
bam-7594	33	9	cases	case	NOUN
bam-7594	33	10	were	be	AUX
bam-7594	33	11	related	relate	VERB
bam-7594	33	12	to	to	ADP
bam-7594	33	13	acinetobacter	acinetobacter	ADV
bam-7594	33	14	(	(	PUNCT
bam-7594	33	15	38.8	38.8	NUM
bam-7594	33	16	%	%	NOUN
bam-7594	33	17	)	)	PUNCT
bam-7594	33	18	,	,	PUNCT
bam-7594	33	19	followed	follow	VERB
bam-7594	33	20	by	by	ADP
bam-7594	33	21	e	e	PROPN
bam-7594	33	22	.coli	.coli	NUM
bam-7594	33	23	(	(	PUNCT
bam-7594	33	24	207	207	NUM
bam-7594	33	25	cases	case	NOUN
bam-7594	33	26	;	;	PUNCT
bam-7594	33	27	22.1	22.1	NUM
bam-7594	33	28	%	%	NOUN
bam-7594	33	29	)	)	PUNCT
bam-7594	33	30	,	,	PUNCT
bam-7594	33	31	staphylococcus	staphylococcus	NOUN
bam-7594	33	32	aeruginosa	aeruginosa	NOUN
bam-7594	33	33	(	(	PUNCT
bam-7594	33	34	140	140	NUM
bam-7594	33	35	;	;	PUNCT
bam-7594	33	36	15	15	NUM
bam-7594	33	37	%	%	NOUN
bam-7594	33	38	)	)	PUNCT
bam-7594	33	39	,	,	PUNCT
bam-7594	33	40	staphylococcus	staphylococcus	NOUN
bam-7594	33	41	aureus	aureus	NOUN
bam-7594	33	42	(	(	PUNCT
bam-7594	33	43	50	50	NUM
bam-7594	33	44	;	;	PUNCT
bam-7594	33	45	5.3	5.3	NUM
bam-7594	33	46	%	%	NOUN
bam-7594	33	47	)	)	PUNCT
bam-7594	33	48	,	,	PUNCT
bam-7594	33	49	and	and	CCONJ
bam-7594	33	50	other	other	ADJ
bam-7594	33	51	agents	agent	NOUN
bam-7594	33	52	including	include	VERB
bam-7594	33	53	coagulase	coagulase	NOUN
bam-7594	33	54	-	-	PUNCT
bam-7594	33	55	negative	negative	ADJ
bam-7594	33	56	staphylococci	staphylococci	NOUN
bam-7594	33	57	,	,	PUNCT
bam-7594	33	58	enterobacter	enterobacter	NOUN
bam-7594	33	59	,	,	PUNCT
bam-7594	33	60	klebsiella	klebsiella	NOUN
bam-7594	33	61	,	,	PUNCT
bam-7594	33	62	and	and	CCONJ
bam-7594	33	63	candida	candida	PROPN
bam-7594	33	64	.	.	PUNCT
bam-7594	34	1	the	the	DET
bam-7594	34	2	type	type	NOUN
bam-7594	34	3	of	of	ADP
bam-7594	34	4	agent	agent	NOUN
bam-7594	34	5	in	in	ADP
bam-7594	34	6	the	the	DET
bam-7594	34	7	studied	studied	ADJ
bam-7594	34	8	years	year	NOUN
bam-7594	34	9	was	be	AUX
bam-7594	34	10	found	find	VERB
bam-7594	34	11	to	to	PART
bam-7594	34	12	be	be	AUX
bam-7594	34	13	significantly	significantly	ADV
bam-7594	34	14	different	different	ADJ
bam-7594	34	15	(	(	PUNCT
bam-7594	34	16	p	p	NOUN
bam-7594	34	17	=	=	NOUN
bam-7594	34	18	0.001	0.001	NUM
bam-7594	34	19	)	)	PUNCT
bam-7594	34	20	,	,	PUNCT
bam-7594	34	21	so	so	SCONJ
bam-7594	34	22	that	that	SCONJ
bam-7594	34	23	pseudomonas	pseudomona	NOUN
bam-7594	34	24	decreased	decrease	VERB
bam-7594	34	25	and	and	CCONJ
bam-7594	34	26	acinetobacter	acinetobacter	ADV
bam-7594	34	27	showed	show	VERB
bam-7594	34	28	an	an	DET
bam-7594	34	29	increased	increase	VERB
bam-7594	34	30	incidence	incidence	NOUN
bam-7594	34	31	.	.	PUNCT
bam-7594	35	1	regarding	regard	VERB
bam-7594	35	2	the	the	DET
bam-7594	35	3	frequency	frequency	NOUN
bam-7594	35	4	of	of	ADP
bam-7594	35	5	resistance	resistance	NOUN
bam-7594	35	6	to	to	ADP
bam-7594	35	7	vancomycin	vancomycin	PROPN
bam-7594	35	8	,	,	PUNCT
bam-7594	35	9	5	5	NUM
bam-7594	35	10	cases	case	NOUN
bam-7594	35	11	(	(	PUNCT
bam-7594	35	12	93.7	93.7	NUM
bam-7594	35	13	%	%	NOUN
bam-7594	35	14	)	)	PUNCT
bam-7594	35	15	were	be	AUX
bam-7594	35	16	susceptible	susceptible	ADJ
bam-7594	35	17	to	to	ADP
bam-7594	35	18	vancomycin	vancomycin	PROPN
bam-7594	35	19	and	and	CCONJ
bam-7594	35	20	7	7	NUM
bam-7594	35	21	cases	case	NOUN
bam-7594	35	22	(	(	PUNCT
bam-7594	35	23	6.3	6.3	NUM
bam-7594	35	24	%	%	NOUN
bam-7594	35	25	)	)	PUNCT
bam-7594	35	26	were	be	AUX
bam-7594	35	27	resistant	resistant	ADJ
bam-7594	35	28	.	.	PUNCT
bam-7594	36	1	frequency	frequency	NOUN
bam-7594	36	2	of	of	ADP
bam-7594	36	3	vancomycin	vancomycin	PROPN
bam-7594	36	4	resistance	resistance	NOUN
bam-7594	36	5	in	in	ADP
bam-7594	36	6	patients	patient	NOUN
bam-7594	36	7	was	be	AUX
bam-7594	36	8	not	not	PART
bam-7594	36	9	significantly	significantly	ADV
bam-7594	36	10	different	different	ADJ
bam-7594	36	11	in	in	ADP
bam-7594	36	12	studied	study	VERB
bam-7594	36	13	years	year	NOUN
bam-7594	36	14	(	(	PUNCT
bam-7594	36	15	p	p	X
bam-7594	36	16	>	>	X
bam-7594	36	17	0.05	0.05	NUM
bam-7594	36	18	)	)	PUNCT
bam-7594	36	19	.	.	PUNCT
bam-7594	37	1	regarding	regard	VERB
bam-7594	37	2	the	the	DET
bam-7594	37	3	frequency	frequency	NOUN
bam-7594	37	4	of	of	ADP
bam-7594	37	5	oxacillin	oxacillin	PROPN
bam-7594	37	6	resistance	resistance	NOUN
bam-7594	37	7	,	,	PUNCT
bam-7594	37	8	30	30	NUM
bam-7594	37	9	cases	case	NOUN
bam-7594	37	10	(	(	PUNCT
bam-7594	37	11	42.7	42.7	NUM
bam-7594	37	12	%	%	NOUN
bam-7594	37	13	)	)	PUNCT
bam-7594	37	14	were	be	AUX
bam-7594	37	15	susceptible	susceptible	ADJ
bam-7594	37	16	to	to	ADP
bam-7594	37	17	oxacillin	oxacillin	NOUN
bam-7594	37	18	and	and	CCONJ
bam-7594	37	19	40	40	NUM
bam-7594	37	20	were	be	AUX
bam-7594	37	21	resistant	resistant	ADJ
bam-7594	37	22	.	.	PUNCT
bam-7594	38	1	there	there	PRON
bam-7594	38	2	was	be	VERB
bam-7594	38	3	no	no	DET
bam-7594	38	4	significant	significant	ADJ
bam-7594	38	5	difference	difference	NOUN
bam-7594	38	6	in	in	ADP
bam-7594	38	7	the	the	DET
bam-7594	38	8	frequency	frequency	NOUN
bam-7594	38	9	of	of	ADP
bam-7594	38	10	oxacillin	oxacillin	ADJ
bam-7594	38	11	resistance	resistance	NOUN
bam-7594	38	12	in	in	ADP
bam-7594	38	13	patients	patient	NOUN
bam-7594	38	14	during	during	ADP
bam-7594	38	15	the	the	DET
bam-7594	38	16	studied	studied	ADJ
bam-7594	38	17	years	year	NOUN
bam-7594	38	18	(	(	PUNCT
bam-7594	38	19	p	p	X
bam-7594	38	20	>	>	X
bam-7594	38	21	0.05	0.05	NUM
bam-7594	38	22	)	)	PUNCT
bam-7594	38	23	.	.	PUNCT
bam-7594	39	1	resistance	resistance	NOUN
bam-7594	39	2	to	to	ADP
bam-7594	39	3	ampicilin	ampicilin	NOUN
bam-7594	39	4	/	/	SYM
bam-7594	39	5	sulbactam	sulbactam	NOUN
bam-7594	39	6	was	be	AUX
bam-7594	39	7	seen	see	VERB
bam-7594	39	8	in	in	ADP
bam-7594	39	9	152	152	NUM
bam-7594	39	10	cases	case	NOUN
bam-7594	39	11	(	(	PUNCT
bam-7594	39	12	39	39	NUM
bam-7594	39	13	%	%	NOUN
bam-7594	39	14	)	)	PUNCT
bam-7594	39	15	,	,	PUNCT
bam-7594	39	16	while	while	SCONJ
bam-7594	39	17	238	238	NUM
bam-7594	39	18	cases	case	NOUN
bam-7594	39	19	(	(	PUNCT
bam-7594	39	20	61	61	NUM
bam-7594	39	21	%	%	NOUN
bam-7594	39	22	)	)	PUNCT
bam-7594	39	23	were	be	AUX
bam-7594	39	24	susceptible	susceptible	ADJ
bam-7594	39	25	.	.	PUNCT
bam-7594	40	1	distribution	distribution	NOUN
bam-7594	40	2	of	of	ADP
bam-7594	40	3	ampicillin	ampicillin	NOUN
bam-7594	40	4	/	/	SYM
bam-7594	40	5	sulbactam	sulbactam	NOUN
bam-7594	40	6	resistance	resistance	NOUN
bam-7594	40	7	in	in	ADP
bam-7594	40	8	patients	patient	NOUN
bam-7594	40	9	in	in	ADP
bam-7594	40	10	studied	studied	ADJ
bam-7594	40	11	years	year	NOUN
bam-7594	40	12	was	be	AUX
bam-7594	40	13	demonstrated	demonstrate	VERB
bam-7594	40	14	to	to	PART
bam-7594	40	15	be	be	AUX
bam-7594	40	16	significant	significant	ADJ
bam-7594	40	17	,	,	PUNCT
bam-7594	40	18	where	where	SCONJ
bam-7594	40	19	had	have	VERB
bam-7594	40	20	u	u	NOUN
bam-7594	40	21	pattern	pattern	NOUN
bam-7594	40	22	(	(	PUNCT
bam-7594	40	23	p	p	X
bam-7594	40	24	=	=	NOUN
bam-7594	40	25	0.014	0.014	NUM
bam-7594	40	26	)	)	PUNCT
bam-7594	40	27	.	.	PUNCT
bam-7594	41	1	moreover	moreover	ADV
bam-7594	41	2	,	,	PUNCT
bam-7594	41	3	the	the	DET
bam-7594	41	4	resistance	resistance	NOUN
bam-7594	41	5	of	of	ADP
bam-7594	41	6	piperacillin	piperacillin	PROPN
bam-7594	41	7	/	/	SYM
bam-7594	41	8	tazobactam	tazobactam	PROPN
bam-7594	41	9	was	be	AUX
bam-7594	41	10	seen	see	VERB
bam-7594	41	11	in	in	ADP
bam-7594	41	12	272	272	NUM
bam-7594	41	13	cases	case	NOUN
bam-7594	41	14	(	(	PUNCT
bam-7594	41	15	56	56	NUM
bam-7594	41	16	%	%	NOUN
bam-7594	41	17	)	)	PUNCT
bam-7594	41	18	,	,	PUNCT
bam-7594	41	19	while	while	SCONJ
bam-7594	41	20	214	214	NUM
bam-7594	41	21	(	(	PUNCT
bam-7594	41	22	44	44	NUM
bam-7594	41	23	%	%	NOUN
bam-7594	41	24	)	)	PUNCT
bam-7594	41	25	were	be	AUX
bam-7594	41	26	susceptible	susceptible	ADJ
bam-7594	41	27	.	.	PUNCT
bam-7594	42	1	it	it	PRON
bam-7594	42	2	is	be	AUX
bam-7594	42	3	worth	worth	ADJ
bam-7594	42	4	noting	note	VERB
bam-7594	42	5	that	that	SCONJ
bam-7594	42	6	resistance	resistance	NOUN
bam-7594	42	7	to	to	ADP
bam-7594	42	8	piperacillin	piperacillin	PROPN
bam-7594	42	9	/	/	SYM
bam-7594	42	10	tazobactam	tazobactam	NOUN
bam-7594	42	11	in	in	ADP
bam-7594	42	12	patients	patient	NOUN
bam-7594	42	13	showed	show	VERB
bam-7594	42	14	a	a	DET
bam-7594	42	15	significant	significant	ADJ
bam-7594	42	16	level	level	NOUN
bam-7594	42	17	where	where	SCONJ
bam-7594	42	18	it	it	PRON
bam-7594	42	19	showed	show	VERB
bam-7594	42	20	an	an	DET
bam-7594	42	21	incremental	incremental	ADJ
bam-7594	42	22	pattern	pattern	NOUN
bam-7594	42	23	(	(	PUNCT
bam-7594	42	24	p	p	X
bam-7594	42	25	=	=	NOUN
bam-7594	42	26	0.037	0.037	NUM
bam-7594	42	27	)	)	PUNCT
bam-7594	42	28	.	.	PUNCT
bam-7594	43	1	furthermore	furthermore	ADV
bam-7594	43	2	,	,	PUNCT
bam-7594	43	3	32	32	NUM
bam-7594	43	4	cases	case	NOUN
bam-7594	43	5	(	(	PUNCT
bam-7594	43	6	43.2	43.2	NUM
bam-7594	43	7	%	%	NOUN
bam-7594	43	8	)	)	PUNCT
bam-7594	43	9	revealed	reveal	VERB
bam-7594	43	10	resistance	resistance	NOUN
bam-7594	43	11	to	to	ADP
bam-7594	43	12	cefazolin	cefazolin	PROPN
bam-7594	43	13	,	,	PUNCT
bam-7594	43	14	while	while	SCONJ
bam-7594	43	15	42	42	NUM
bam-7594	43	16	(	(	PUNCT
bam-7594	43	17	56.8	56.8	NUM
bam-7594	43	18	%	%	NOUN
bam-7594	43	19	)	)	PUNCT
bam-7594	43	20	were	be	AUX
bam-7594	43	21	susceptible	susceptible	ADJ
bam-7594	43	22	.	.	PUNCT
bam-7594	44	1	the	the	DET
bam-7594	44	2	frequency	frequency	NOUN
bam-7594	44	3	of	of	ADP
bam-7594	44	4	resistance	resistance	NOUN
bam-7594	44	5	to	to	ADP
bam-7594	44	6	cefazolin	cefazolin	PROPN
bam-7594	44	7	did	do	AUX
bam-7594	44	8	not	not	PART
bam-7594	44	9	show	show	VERB
bam-7594	44	10	significant	significant	ADJ
bam-7594	44	11	difference	difference	NOUN
bam-7594	44	12	among	among	ADP
bam-7594	44	13	patients	patient	NOUN
bam-7594	44	14	in	in	ADP
bam-7594	44	15	studied	study	VERB
bam-7594	44	16	years	year	NOUN
bam-7594	44	17	(	(	PUNCT
bam-7594	44	18	p	p	X
bam-7594	44	19	>	>	X
bam-7594	44	20	0.05	0.05	NUM
bam-7594	44	21	)	)	PUNCT
bam-7594	44	22	.	.	PUNCT
bam-7594	45	1	in	in	ADP
bam-7594	45	2	addition	addition	NOUN
bam-7594	45	3	,	,	PUNCT
bam-7594	45	4	frequency	frequency	NOUN
bam-7594	45	5	of	of	ADP
bam-7594	45	6	cefoxitin	cefoxitin	NOUN
bam-7594	45	7	resistance	resistance	NOUN
bam-7594	45	8	was	be	AUX
bam-7594	45	9	found	find	VERB
bam-7594	45	10	in	in	ADP
bam-7594	45	11	25	25	NUM
bam-7594	45	12	cases	case	NOUN
bam-7594	45	13	(	(	PUNCT
bam-7594	45	14	43.9	43.9	NUM
bam-7594	45	15	%	%	NOUN
bam-7594	45	16	)	)	PUNCT
bam-7594	45	17	,	,	PUNCT
bam-7594	45	18	however	however	ADV
bam-7594	45	19	,	,	PUNCT
bam-7594	45	20	32	32	NUM
bam-7594	45	21	cases	case	NOUN
bam-7594	45	22	(	(	PUNCT
bam-7594	45	23	56.1	56.1	NUM
bam-7594	45	24	%	%	NOUN
bam-7594	45	25	)	)	PUNCT
bam-7594	45	26	were	be	AUX
bam-7594	45	27	susceptible	susceptible	ADJ
bam-7594	45	28	to	to	ADP
bam-7594	45	29	this	this	DET
bam-7594	45	30	antibiotic	antibiotic	NOUN
bam-7594	45	31	.	.	PUNCT
bam-7594	46	1	there	there	PRON
bam-7594	46	2	was	be	VERB
bam-7594	46	3	no	no	DET
bam-7594	46	4	significant	significant	ADJ
bam-7594	46	5	difference	difference	NOUN
bam-7594	46	6	in	in	ADP
bam-7594	46	7	frequency	frequency	NOUN
bam-7594	46	8	distribution	distribution	NOUN
bam-7594	46	9	of	of	ADP
bam-7594	46	10	table	table	NOUN
bam-7594	46	11	1	1	NUM
bam-7594	46	12	.	.	PUNCT
bam-7594	46	13	frequency	frequency	NOUN
bam-7594	46	14	distribution	distribution	NOUN
bam-7594	46	15	of	of	ADP
bam-7594	46	16	the	the	DET
bam-7594	46	17	agent	agent	NOUN
bam-7594	46	18	type	type	NOUN
bam-7594	46	19	in	in	ADP
bam-7594	46	20	studied	study	VERB
bam-7594	46	21	years	year	NOUN
bam-7594	46	22	2014	2014	NUM
bam-7594	46	23	2013	2013	NUM
bam-7594	46	24	2015	2015	NUM
bam-7594	46	25	non	non	X
bam-7594	46	26	co	co	X
bam-7594	46	27	mmerc	mmerc	PROPN
bam-7594	46	28	ial	ial	PROPN
bam-7594	46	29	us	us	PROPN
bam-7594	46	30	e	e	NOUN
bam-7594	46	31	o	o	NOUN
bam-7594	46	32	nly	nly	ADV
bam-7594	46	33	antibiotic	antibiotic	ADJ
bam-7594	46	34	resistance	resistance	NOUN
bam-7594	46	35	of	of	ADP
bam-7594	46	36	nosocomial	nosocomial	ADJ
bam-7594	46	37	infections	infection	NOUN
bam-7594	46	38	eur	eur	PROPN
bam-7594	46	39	j	j	PROPN
bam-7594	46	40	transl	transl	PROPN
bam-7594	46	41	myol	myol	ADV
bam-7594	46	42	28	28	NUM
bam-7594	46	43	(	(	PUNCT
bam-7594	46	44	3	3	NUM
bam-7594	46	45	):	):	PUNCT
bam-7594	46	46	304	304	NUM
bam-7594	46	47	-	-	SYM
bam-7594	46	48	308	308	NUM
bam-7594	46	49	,	,	PUNCT
bam-7594	46	50	2018	2018	NUM
bam-7594	46	51	306	306	NUM
bam-7594	46	52	cefoxitin	cefoxitin	NOUN
bam-7594	46	53	resistance	resistance	NOUN
bam-7594	46	54	in	in	ADP
bam-7594	46	55	patients	patient	NOUN
bam-7594	46	56	during	during	ADP
bam-7594	46	57	the	the	DET
bam-7594	46	58	studied	studied	ADJ
bam-7594	46	59	years	year	NOUN
bam-7594	46	60	(	(	PUNCT
bam-7594	46	61	p	p	X
bam-7594	46	62	>	>	X
bam-7594	46	63	0.05	0.05	NUM
bam-7594	46	64	)	)	PUNCT
bam-7594	46	65	.	.	PUNCT
bam-7594	47	1	our	our	PRON
bam-7594	47	2	findings	finding	NOUN
bam-7594	47	3	demonstrated	demonstrate	VERB
bam-7594	47	4	that	that	SCONJ
bam-7594	47	5	63	63	NUM
bam-7594	47	6	cases	case	NOUN
bam-7594	47	7	(	(	PUNCT
bam-7594	47	8	11.9	11.9	NUM
bam-7594	47	9	%	%	NOUN
bam-7594	47	10	)	)	PUNCT
bam-7594	47	11	were	be	AUX
bam-7594	47	12	susceptible	susceptible	ADJ
bam-7594	47	13	to	to	ADP
bam-7594	47	14	ceftriaxone	ceftriaxone	NOUN
bam-7594	47	15	and	and	CCONJ
bam-7594	47	16	466	466	NUM
bam-7594	47	17	(	(	PUNCT
bam-7594	47	18	88.1	88.1	NUM
bam-7594	47	19	%	%	NOUN
bam-7594	47	20	)	)	PUNCT
bam-7594	47	21	were	be	AUX
bam-7594	47	22	resistant	resistant	ADJ
bam-7594	47	23	to	to	ADP
bam-7594	47	24	ceftriaxone	ceftriaxone	PROPN
bam-7594	47	25	.	.	PUNCT
bam-7594	48	1	the	the	DET
bam-7594	48	2	frequency	frequency	NOUN
bam-7594	48	3	of	of	ADP
bam-7594	48	4	resistance	resistance	NOUN
bam-7594	48	5	to	to	ADP
bam-7594	48	6	ceftriaxone	ceftriaxone	PROPN
bam-7594	48	7	showed	show	VERB
bam-7594	48	8	significant	significant	ADJ
bam-7594	48	9	changes	change	NOUN
bam-7594	48	10	,	,	PUNCT
bam-7594	48	11	indicating	indicate	VERB
bam-7594	48	12	an	an	DET
bam-7594	48	13	incremental	incremental	ADJ
bam-7594	48	14	pattern	pattern	NOUN
bam-7594	48	15	(	(	PUNCT
bam-7594	48	16	p	p	X
bam-7594	48	17	=	=	NOUN
bam-7594	48	18	0.010	0.010	NUM
bam-7594	48	19	)	)	PUNCT
bam-7594	48	20	.	.	PUNCT
bam-7594	49	1	with	with	ADP
bam-7594	49	2	regard	regard	NOUN
bam-7594	49	3	to	to	ADP
bam-7594	49	4	the	the	DET
bam-7594	49	5	frequency	frequency	NOUN
bam-7594	49	6	of	of	ADP
bam-7594	49	7	resistance	resistance	NOUN
bam-7594	49	8	to	to	ADP
bam-7594	49	9	ceftazidime	ceftazidime	NOUN
bam-7594	49	10	,	,	PUNCT
bam-7594	49	11	49	49	NUM
bam-7594	49	12	cases	case	NOUN
bam-7594	49	13	(	(	PUNCT
bam-7594	49	14	9.9	9.9	NUM
bam-7594	49	15	%	%	NOUN
bam-7594	49	16	)	)	PUNCT
bam-7594	49	17	revealed	reveal	VERB
bam-7594	49	18	susceptibility	susceptibility	NOUN
bam-7594	49	19	to	to	ADP
bam-7594	49	20	this	this	DET
bam-7594	49	21	antibiotic	antibiotic	NOUN
bam-7594	49	22	,	,	PUNCT
bam-7594	49	23	while	while	SCONJ
bam-7594	49	24	445	445	NUM
bam-7594	49	25	(	(	PUNCT
bam-7594	49	26	90.1	90.1	NUM
bam-7594	49	27	%	%	NOUN
bam-7594	49	28	)	)	PUNCT
bam-7594	49	29	confirmed	confirm	VERB
bam-7594	49	30	antibiotic	antibiotic	ADJ
bam-7594	49	31	resistance	resistance	NOUN
bam-7594	49	32	.	.	PUNCT
bam-7594	50	1	as	as	ADP
bam-7594	50	2	a	a	DET
bam-7594	50	3	result	result	NOUN
bam-7594	50	4	,	,	PUNCT
bam-7594	50	5	significant	significant	ADJ
bam-7594	50	6	changes	change	NOUN
bam-7594	50	7	were	be	AUX
bam-7594	50	8	found	find	VERB
bam-7594	50	9	in	in	ADP
bam-7594	50	10	the	the	DET
bam-7594	50	11	frequency	frequency	NOUN
bam-7594	50	12	of	of	ADP
bam-7594	50	13	resistance	resistance	NOUN
bam-7594	50	14	to	to	ADP
bam-7594	50	15	ceftazidime	ceftazidime	NOUN
bam-7594	50	16	in	in	ADP
bam-7594	50	17	patients	patient	NOUN
bam-7594	50	18	,	,	PUNCT
bam-7594	50	19	where	where	SCONJ
bam-7594	50	20	an	an	DET
bam-7594	50	21	incremental	incremental	ADJ
bam-7594	50	22	pattern	pattern	NOUN
bam-7594	50	23	was	be	AUX
bam-7594	50	24	achieved	achieve	VERB
bam-7594	50	25	(	(	PUNCT
bam-7594	50	26	p	p	NOUN
bam-7594	50	27	=	=	NOUN
bam-7594	50	28	0.001	0.001	NUM
bam-7594	50	29	)	)	PUNCT
bam-7594	50	30	.	.	PUNCT
bam-7594	51	1	regarding	regard	VERB
bam-7594	51	2	resistance	resistance	NOUN
bam-7594	51	3	to	to	ADP
bam-7594	51	4	cefepime	cefepime	NOUN
bam-7594	51	5	,	,	PUNCT
bam-7594	51	6	103	103	NUM
bam-7594	51	7	cases	case	NOUN
bam-7594	51	8	(	(	PUNCT
bam-7594	51	9	20.2	20.2	NUM
bam-7594	51	10	%	%	NOUN
bam-7594	51	11	)	)	PUNCT
bam-7594	51	12	showed	show	VERB
bam-7594	51	13	sensitivity	sensitivity	NOUN
bam-7594	51	14	and	and	CCONJ
bam-7594	51	15	406	406	NUM
bam-7594	51	16	(	(	PUNCT
bam-7594	51	17	79.8	79.8	NUM
bam-7594	51	18	%	%	NOUN
bam-7594	51	19	)	)	PUNCT
bam-7594	51	20	were	be	AUX
bam-7594	51	21	resistant	resistant	ADJ
bam-7594	51	22	.	.	PUNCT
bam-7594	52	1	the	the	DET
bam-7594	52	2	frequency	frequency	NOUN
bam-7594	52	3	of	of	ADP
bam-7594	52	4	resistance	resistance	NOUN
bam-7594	52	5	to	to	ADP
bam-7594	52	6	imipenem	imipenem	PROPN
bam-7594	52	7	among	among	ADP
bam-7594	52	8	patients	patient	NOUN
bam-7594	52	9	was	be	AUX
bam-7594	52	10	significantly	significantly	ADV
bam-7594	52	11	higher	high	ADJ
bam-7594	52	12	in	in	ADP
bam-7594	52	13	studied	study	VERB
bam-7594	52	14	years	year	NOUN
bam-7594	52	15	and	and	CCONJ
bam-7594	52	16	had	have	VERB
bam-7594	52	17	an	an	DET
bam-7594	52	18	incremental	incremental	ADJ
bam-7594	52	19	pattern	pattern	NOUN
bam-7594	52	20	(	(	PUNCT
bam-7594	52	21	p	p	X
bam-7594	52	22	=	=	NOUN
bam-7594	52	23	0.001	0.001	NUM
bam-7594	52	24	)	)	PUNCT
bam-7594	52	25	.	.	PUNCT
bam-7594	53	1	in	in	ADP
bam-7594	53	2	the	the	DET
bam-7594	53	3	studied	studied	ADJ
bam-7594	53	4	years	year	NOUN
bam-7594	53	5	,	,	PUNCT
bam-7594	53	6	132	132	NUM
bam-7594	53	7	cases	case	NOUN
bam-7594	53	8	(	(	PUNCT
bam-7594	53	9	24.8	24.8	NUM
bam-7594	53	10	%	%	NOUN
bam-7594	53	11	)	)	PUNCT
bam-7594	53	12	were	be	AUX
bam-7594	53	13	sensitive	sensitive	ADJ
bam-7594	53	14	to	to	ADP
bam-7594	53	15	imipenem	imipenem	PROPN
bam-7594	53	16	and	and	CCONJ
bam-7594	53	17	400	400	NUM
bam-7594	53	18	cases	case	NOUN
bam-7594	53	19	(	(	PUNCT
bam-7594	53	20	75.2	75.2	NUM
bam-7594	53	21	%	%	NOUN
bam-7594	53	22	)	)	PUNCT
bam-7594	53	23	showed	show	VERB
bam-7594	53	24	resistance	resistance	NOUN
bam-7594	53	25	.	.	PUNCT
bam-7594	54	1	the	the	DET
bam-7594	54	2	frequency	frequency	NOUN
bam-7594	54	3	of	of	ADP
bam-7594	54	4	imipenem	imipenem	PROPN
bam-7594	54	5	resistance	resistance	NOUN
bam-7594	54	6	in	in	ADP
bam-7594	54	7	patients	patient	NOUN
bam-7594	54	8	in	in	ADP
bam-7594	54	9	studied	studied	ADJ
bam-7594	54	10	years	year	NOUN
bam-7594	54	11	did	do	AUX
bam-7594	54	12	not	not	PART
bam-7594	54	13	reveal	reveal	VERB
bam-7594	54	14	a	a	DET
bam-7594	54	15	significant	significant	ADJ
bam-7594	54	16	difference	difference	NOUN
bam-7594	54	17	(	(	PUNCT
bam-7594	54	18	p	p	X
bam-7594	54	19	>	>	X
bam-7594	54	20	0.05	0.05	NUM
bam-7594	54	21	)	)	PUNCT
bam-7594	54	22	.	.	PUNCT
bam-7594	55	1	moreover	moreover	ADV
bam-7594	55	2	,	,	PUNCT
bam-7594	55	3	resistance	resistance	NOUN
bam-7594	55	4	to	to	ADP
bam-7594	55	5	meropenem	meropenem	PROPN
bam-7594	55	6	was	be	AUX
bam-7594	55	7	also	also	ADV
bam-7594	55	8	found	find	VERB
bam-7594	55	9	in	in	ADP
bam-7594	55	10	353	353	NUM
bam-7594	55	11	cases	case	NOUN
bam-7594	55	12	(	(	PUNCT
bam-7594	55	13	67.5	67.5	NUM
bam-7594	55	14	%	%	NOUN
bam-7594	55	15	)	)	PUNCT
bam-7594	55	16	,	,	PUNCT
bam-7594	55	17	but	but	CCONJ
bam-7594	55	18	the	the	DET
bam-7594	55	19	sensitivity	sensitivity	NOUN
bam-7594	55	20	of	of	ADP
bam-7594	55	21	this	this	DET
bam-7594	55	22	biotype	biotype	NOUN
bam-7594	55	23	was	be	AUX
bam-7594	55	24	found	find	VERB
bam-7594	55	25	in	in	ADP
bam-7594	55	26	170	170	NUM
bam-7594	55	27	(	(	PUNCT
bam-7594	55	28	32.5	32.5	NUM
bam-7594	55	29	%	%	NOUN
bam-7594	55	30	)	)	PUNCT
bam-7594	55	31	patients	patient	NOUN
bam-7594	55	32	.	.	PUNCT
bam-7594	56	1	the	the	DET
bam-7594	56	2	frequency	frequency	NOUN
bam-7594	56	3	of	of	ADP
bam-7594	56	4	resistance	resistance	NOUN
bam-7594	56	5	to	to	ADP
bam-7594	56	6	meropenem	meropenem	PROPN
bam-7594	56	7	in	in	ADP
bam-7594	56	8	patients	patient	NOUN
bam-7594	56	9	demonstrated	demonstrate	VERB
bam-7594	56	10	a	a	DET
bam-7594	56	11	significant	significant	ADJ
bam-7594	56	12	change	change	NOUN
bam-7594	56	13	in	in	ADP
bam-7594	56	14	studied	study	VERB
bam-7594	56	15	years	year	NOUN
bam-7594	56	16	and	and	CCONJ
bam-7594	56	17	had	have	VERB
bam-7594	56	18	a	a	DET
bam-7594	56	19	reverse	reverse	ADJ
bam-7594	56	20	u	u	NOUN
bam-7594	56	21	pattern	pattern	NOUN
bam-7594	56	22	(	(	PUNCT
bam-7594	56	23	p	p	X
bam-7594	56	24	=	=	NOUN
bam-7594	56	25	0.002	0.002	NUM
bam-7594	56	26	)	)	PUNCT
bam-7594	56	27	.	.	PUNCT
bam-7594	57	1	with	with	ADP
bam-7594	57	2	regard	regard	NOUN
bam-7594	57	3	to	to	ADP
bam-7594	57	4	the	the	DET
bam-7594	57	5	frequency	frequency	NOUN
bam-7594	57	6	of	of	ADP
bam-7594	57	7	resistance	resistance	NOUN
bam-7594	57	8	to	to	ADP
bam-7594	57	9	gentamicin	gentamicin	PROPN
bam-7594	57	10	,	,	PUNCT
bam-7594	57	11	88	88	NUM
bam-7594	57	12	cases	case	NOUN
bam-7594	57	13	(	(	PUNCT
bam-7594	57	14	23.1	23.1	NUM
bam-7594	57	15	%	%	NOUN
bam-7594	57	16	)	)	PUNCT
bam-7594	57	17	were	be	AUX
bam-7594	57	18	found	find	VERB
bam-7594	57	19	to	to	PART
bam-7594	57	20	be	be	AUX
bam-7594	57	21	susceptible	susceptible	ADJ
bam-7594	57	22	while	while	SCONJ
bam-7594	57	23	293	293	NUM
bam-7594	57	24	cases	case	NOUN
bam-7594	57	25	(	(	PUNCT
bam-7594	57	26	66.9	66.9	NUM
bam-7594	57	27	%	%	NOUN
bam-7594	57	28	)	)	PUNCT
bam-7594	57	29	were	be	AUX
bam-7594	57	30	identified	identify	VERB
bam-7594	57	31	to	to	PART
bam-7594	57	32	be	be	AUX
bam-7594	57	33	resistant	resistant	ADJ
bam-7594	57	34	.	.	PUNCT
bam-7594	58	1	the	the	DET
bam-7594	58	2	frequency	frequency	NOUN
bam-7594	58	3	of	of	ADP
bam-7594	58	4	resistance	resistance	NOUN
bam-7594	58	5	to	to	ADP
bam-7594	58	6	gentamicin	gentamicin	NOUN
bam-7594	58	7	in	in	ADP
bam-7594	58	8	patients	patient	NOUN
bam-7594	58	9	revealed	reveal	VERB
bam-7594	58	10	significant	significant	ADJ
bam-7594	58	11	changes	change	NOUN
bam-7594	58	12	over	over	ADP
bam-7594	58	13	the	the	DET
bam-7594	58	14	years	year	NOUN
bam-7594	58	15	and	and	CCONJ
bam-7594	58	16	was	be	AUX
bam-7594	58	17	u	u	ADJ
bam-7594	58	18	-	-	ADJ
bam-7594	58	19	shaped	shape	VERB
bam-7594	58	20	pattern	pattern	NOUN
bam-7594	58	21	(	(	PUNCT
bam-7594	58	22	p	p	X
bam-7594	58	23	=	=	NOUN
bam-7594	58	24	0.002	0.002	NUM
bam-7594	58	25	)	)	PUNCT
bam-7594	58	26	.	.	PUNCT
bam-7594	59	1	in	in	ADP
bam-7594	59	2	this	this	DET
bam-7594	59	3	study	study	NOUN
bam-7594	59	4	,	,	PUNCT
bam-7594	59	5	other	other	ADJ
bam-7594	59	6	antibiotics	antibiotic	NOUN
bam-7594	59	7	such	such	ADJ
bam-7594	59	8	as	as	ADP
bam-7594	59	9	amikacin	amikacin	PROPN
bam-7594	59	10	,	,	PUNCT
bam-7594	59	11	ciprofloxacin	ciprofloxacin	PROPN
bam-7594	59	12	,	,	PUNCT
bam-7594	59	13	levofloxacin	levofloxacin	PROPN
bam-7594	59	14	,	,	PUNCT
bam-7594	59	15	nitrofurantoin	nitrofurantoin	NOUN
bam-7594	59	16	,	,	PUNCT
bam-7594	59	17	clostin	clostin	NOUN
bam-7594	59	18	,	,	PUNCT
bam-7594	59	19	and	and	CCONJ
bam-7594	59	20	ampicillin	ampicillin	NOUN
bam-7594	59	21	have	have	AUX
bam-7594	59	22	been	be	AUX
bam-7594	59	23	evaluated	evaluate	VERB
bam-7594	59	24	.	.	PUNCT
bam-7594	60	1	frequency	frequency	NOUN
bam-7594	60	2	of	of	ADP
bam-7594	60	3	resistance	resistance	NOUN
bam-7594	60	4	in	in	ADP
bam-7594	60	5	patients	patient	NOUN
bam-7594	60	6	in	in	ADP
bam-7594	60	7	studied	studied	ADJ
bam-7594	60	8	years	year	NOUN
bam-7594	60	9	revealed	reveal	VERB
bam-7594	60	10	significant	significant	ADJ
bam-7594	60	11	changes	change	NOUN
bam-7594	60	12	where	where	SCONJ
bam-7594	60	13	u	u	NOUN
bam-7594	60	14	shaped	shape	VERB
bam-7594	60	15	patterns	pattern	NOUN
bam-7594	60	16	were	be	AUX
bam-7594	60	17	observed	observe	VERB
bam-7594	60	18	regarding	regard	VERB
bam-7594	60	19	amikacin	amikacin	PROPN
bam-7594	60	20	,	,	PUNCT
bam-7594	60	21	ciprofloxacin	ciprofloxacin	PROPN
bam-7594	60	22	,	,	PUNCT
bam-7594	60	23	levofloxacin.it	levofloxacin.it	PRON
bam-7594	60	24	should	should	AUX
bam-7594	60	25	be	be	AUX
bam-7594	60	26	noted	note	VERB
bam-7594	60	27	that	that	SCONJ
bam-7594	60	28	in	in	ADP
bam-7594	60	29	the	the	DET
bam-7594	60	30	case	case	NOUN
bam-7594	60	31	of	of	ADP
bam-7594	60	32	clostine	clostine	NOUN
bam-7594	60	33	,	,	PUNCT
bam-7594	60	34	a	a	DET
bam-7594	60	35	decreasing	decrease	VERB
bam-7594	60	36	resistance	resistance	NOUN
bam-7594	60	37	pattern	pattern	NOUN
bam-7594	60	38	was	be	AUX
bam-7594	60	39	demonstrated	demonstrate	VERB
bam-7594	60	40	and	and	CCONJ
bam-7594	60	41	an	an	DET
bam-7594	60	42	incremental	incremental	ADJ
bam-7594	60	43	resistance	resistance	NOUN
bam-7594	60	44	pattern	pattern	NOUN
bam-7594	60	45	was	be	AUX
bam-7594	60	46	determined	determine	VERB
bam-7594	60	47	for	for	ADP
bam-7594	60	48	ampicillin	ampicillin	NOUN
bam-7594	60	49	.	.	PUNCT
bam-7594	61	1	it	it	PRON
bam-7594	61	2	is	be	AUX
bam-7594	61	3	worth	worth	ADJ
bam-7594	61	4	noting	note	VERB
bam-7594	61	5	that	that	SCONJ
bam-7594	61	6	there	there	PRON
bam-7594	61	7	were	be	VERB
bam-7594	61	8	no	no	DET
bam-7594	61	9	significant	significant	ADJ
bam-7594	61	10	differences	difference	NOUN
bam-7594	61	11	in	in	ADP
bam-7594	61	12	resistance	resistance	NOUN
bam-7594	61	13	to	to	ADP
bam-7594	61	14	antibiotics	antibiotic	NOUN
bam-7594	61	15	such	such	ADJ
bam-7594	61	16	as	as	ADP
bam-7594	61	17	clindamycin	clindamycin	NOUN
bam-7594	61	18	,	,	PUNCT
bam-7594	61	19	rifampicin	rifampicin	VERB
bam-7594	61	20	,	,	PUNCT
bam-7594	61	21	clotrimazole	clotrimazole	NOUN
bam-7594	61	22	,	,	PUNCT
bam-7594	61	23	linezolid	linezolid	ADJ
bam-7594	61	24	and	and	CCONJ
bam-7594	61	25	nalidixic	nalidixic	ADJ
bam-7594	61	26	acid	acid	NOUN
bam-7594	61	27	in	in	ADP
bam-7594	61	28	studied	study	VERB
bam-7594	61	29	years	year	NOUN
bam-7594	61	30	.	.	PUNCT
bam-7594	62	1	on	on	ADP
bam-7594	62	2	the	the	DET
bam-7594	62	3	other	other	ADJ
bam-7594	62	4	hand	hand	NOUN
bam-7594	62	5	,	,	PUNCT
bam-7594	62	6	diversity	diversity	NOUN
bam-7594	62	7	of	of	ADP
bam-7594	62	8	antibiotic	antibiotic	ADJ
bam-7594	62	9	resistance	resistance	NOUN
bam-7594	62	10	patterns	pattern	NOUN
bam-7594	62	11	based	base	VERB
bam-7594	62	12	on	on	ADP
bam-7594	62	13	age	age	NOUN
bam-7594	62	14	,	,	PUNCT
bam-7594	62	15	gender	gender	NOUN
bam-7594	62	16	type	type	NOUN
bam-7594	62	17	of	of	ADP
bam-7594	62	18	sample	sample	NOUN
bam-7594	62	19	and	and	CCONJ
bam-7594	62	20	type	type	NOUN
bam-7594	62	21	of	of	ADP
bam-7594	62	22	agent	agent	NOUN
bam-7594	62	23	in	in	ADP
bam-7594	62	24	the	the	DET
bam-7594	62	25	subjects	subject	NOUN
bam-7594	62	26	are	be	AUX
bam-7594	62	27	listed	list	VERB
bam-7594	62	28	listed	list	VERB
bam-7594	62	29	in	in	ADP
bam-7594	62	30	tables	table	NOUN
bam-7594	62	31	2	2	NUM
bam-7594	62	32	to	to	ADP
bam-7594	62	33	5	5	NUM
bam-7594	62	34	.	.	PUNCT
bam-7594	63	1	the	the	DET
bam-7594	63	2	findings	finding	NOUN
bam-7594	63	3	of	of	ADP
bam-7594	63	4	this	this	DET
bam-7594	63	5	study	study	NOUN
bam-7594	63	6	revealed	reveal	VERB
bam-7594	63	7	that	that	SCONJ
bam-7594	63	8	the	the	DET
bam-7594	63	9	frequency	frequency	NOUN
bam-7594	63	10	distribution	distribution	NOUN
bam-7594	63	11	of	of	ADP
bam-7594	63	12	the	the	DET
bam-7594	63	13	agent	agent	NOUN
bam-7594	63	14	type	type	NOUN
bam-7594	63	15	had	have	VERB
bam-7594	63	16	significant	significant	ADJ
bam-7594	63	17	changes	change	NOUN
bam-7594	63	18	(	(	PUNCT
bam-7594	63	19	p	p	X
bam-7594	63	20	=	=	NOUN
bam-7594	63	21	0.024	0.024	NUM
bam-7594	63	22	):	):	PUNCT
bam-7594	63	23	gram	gram	PROPN
bam-7594	63	24	negative	negative	ADJ
bam-7594	63	25	bacilli	bacilli	NOUN
bam-7594	63	26	increased	increase	VERB
bam-7594	63	27	notably	notably	ADV
bam-7594	63	28	,	,	PUNCT
bam-7594	63	29	while	while	SCONJ
bam-7594	63	30	gram	gram	PROPN
bam-7594	63	31	positive	positive	ADJ
bam-7594	63	32	cocci	cocci	NOUN
bam-7594	63	33	decreased	decrease	VERB
bam-7594	63	34	(	(	PUNCT
bam-7594	63	35	table	table	NOUN
bam-7594	63	36	1	1	NUM
bam-7594	63	37	)	)	PUNCT
bam-7594	63	38	.	.	PUNCT
bam-7594	64	1	the	the	DET
bam-7594	64	2	trends	trend	NOUN
bam-7594	64	3	in	in	ADP
bam-7594	64	4	antibiotic	antibiotic	ADJ
bam-7594	64	5	resistance	resistance	NOUN
bam-7594	64	6	pattern	pattern	NOUN
bam-7594	64	7	of	of	ADP
bam-7594	64	8	bacterial	bacterial	ADJ
bam-7594	64	9	agents	agent	NOUN
bam-7594	64	10	based	base	VERB
bam-7594	64	11	on	on	ADP
bam-7594	64	12	the	the	DET
bam-7594	64	13	age	age	NOUN
bam-7594	64	14	of	of	ADP
bam-7594	64	15	the	the	DET
bam-7594	64	16	subjects	subject	NOUN
bam-7594	64	17	was	be	AUX
bam-7594	64	18	significant	significant	ADJ
bam-7594	64	19	in	in	ADP
bam-7594	64	20	few	few	ADJ
bam-7594	64	21	cases	case	NOUN
bam-7594	64	22	(	(	PUNCT
bam-7594	64	23	p	p	X
bam-7594	64	24	<	<	NOUN
bam-7594	64	25	0.05	0.05	NUM
bam-7594	64	26	)	)	PUNCT
bam-7594	64	27	that	that	PRON
bam-7594	64	28	are	be	AUX
bam-7594	64	29	shown	show	VERB
bam-7594	64	30	in	in	ADP
bam-7594	64	31	table	table	NOUN
bam-7594	64	32	2	2	NUM
bam-7594	64	33	.	.	PUNCT
bam-7594	65	1	the	the	DET
bam-7594	65	2	change	change	NOUN
bam-7594	65	3	in	in	ADP
bam-7594	65	4	antibiotic	antibiotic	ADJ
bam-7594	65	5	resistance	resistance	NOUN
bam-7594	65	6	pattern	pattern	NOUN
bam-7594	65	7	based	base	VERB
bam-7594	65	8	on	on	ADP
bam-7594	65	9	gender	gender	NOUN
bam-7594	65	10	was	be	AUX
bam-7594	65	11	also	also	ADV
bam-7594	65	12	significant	significant	ADJ
bam-7594	65	13	in	in	ADP
bam-7594	65	14	few	few	ADJ
bam-7594	65	15	cases	case	NOUN
bam-7594	65	16	(	(	PUNCT
bam-7594	65	17	table	table	NOUN
bam-7594	65	18	3	3	NUM
bam-7594	65	19	;	;	PUNCT
bam-7594	65	20	p	p	X
bam-7594	65	21	<	<	NOUN
bam-7594	65	22	0.05	0.05	NUM
bam-7594	65	23	)	)	PUNCT
bam-7594	65	24	.	.	PUNCT
bam-7594	66	1	the	the	DET
bam-7594	66	2	trend	trend	NOUN
bam-7594	66	3	of	of	ADP
bam-7594	66	4	changing	change	VERB
bam-7594	66	5	the	the	DET
bam-7594	66	6	patterns	pattern	NOUN
bam-7594	66	7	of	of	ADP
bam-7594	66	8	antibiotic	antibiotic	ADJ
bam-7594	66	9	resistance	resistance	NOUN
bam-7594	66	10	based	base	VERB
bam-7594	66	11	on	on	ADP
bam-7594	66	12	the	the	DET
bam-7594	66	13	type	type	NOUN
bam-7594	66	14	of	of	ADP
bam-7594	66	15	sample	sample	NOUN
bam-7594	66	16	was	be	AUX
bam-7594	66	17	significant	significant	ADJ
bam-7594	66	18	in	in	ADP
bam-7594	66	19	some	some	DET
bam-7594	66	20	cases	case	NOUN
bam-7594	66	21	(	(	PUNCT
bam-7594	66	22	p	p	X
bam-7594	66	23	<	<	X
bam-7594	66	24	0.05	0.05	NUM
bam-7594	66	25	)	)	PUNCT
bam-7594	66	26	,	,	PUNCT
bam-7594	66	27	that	that	PRON
bam-7594	66	28	are	be	AUX
bam-7594	66	29	shown	show	VERB
bam-7594	66	30	in	in	ADP
bam-7594	66	31	table	table	NOUN
bam-7594	66	32	4	4	NUM
bam-7594	66	33	.	.	PUNCT
bam-7594	67	1	in	in	ADP
bam-7594	67	2	addition	addition	NOUN
bam-7594	67	3	,	,	PUNCT
bam-7594	67	4	there	there	PRON
bam-7594	67	5	was	be	VERB
bam-7594	67	6	a	a	DET
bam-7594	67	7	significant	significant	ADJ
bam-7594	67	8	relationship	relationship	NOUN
bam-7594	67	9	between	between	ADP
bam-7594	67	10	the	the	DET
bam-7594	67	11	trend	trend	NOUN
bam-7594	67	12	of	of	ADP
bam-7594	67	13	antibiotic	antibiotic	ADJ
bam-7594	67	14	resistance	resistance	NOUN
bam-7594	67	15	pattern	pattern	NOUN
bam-7594	67	16	and	and	CCONJ
bam-7594	67	17	type	type	NOUN
bam-7594	67	18	of	of	ADP
bam-7594	67	19	agent	agent	NOUN
bam-7594	67	20	in	in	ADP
bam-7594	67	21	most	most	ADJ
bam-7594	67	22	cases	case	NOUN
bam-7594	67	23	(	(	PUNCT
bam-7594	67	24	table	table	NOUN
bam-7594	67	25	5	5	NUM
bam-7594	67	26	;	;	PUNCT
bam-7594	67	27	p	p	X
bam-7594	67	28	<	<	NOUN
bam-7594	67	29	0.05	0.05	NUM
bam-7594	67	30	)	)	PUNCT
bam-7594	67	31	.	.	PUNCT
bam-7594	68	1	establishing	establish	VERB
bam-7594	68	2	surveillance	surveillance	NOUN
bam-7594	68	3	systems	system	NOUN
bam-7594	68	4	for	for	ADP
bam-7594	68	5	tracking	track	VERB
bam-7594	68	6	the	the	DET
bam-7594	68	7	trend	trend	NOUN
bam-7594	68	8	of	of	ADP
bam-7594	68	9	infectious	infectious	ADJ
bam-7594	68	10	diseases	disease	NOUN
bam-7594	68	11	is	be	AUX
bam-7594	68	12	of	of	ADP
bam-7594	68	13	particular	particular	ADJ
bam-7594	68	14	importance.6	importance.6	AUX
bam-7594	68	15	this	this	PRON
bam-7594	68	16	is	be	AUX
bam-7594	68	17	especially	especially	ADV
bam-7594	68	18	true	true	ADJ
bam-7594	68	19	for	for	ADP
bam-7594	68	20	antibiotic	antibiotic	ADJ
bam-7594	68	21	resistance	resistance	NOUN
bam-7594	68	22	because	because	SCONJ
bam-7594	68	23	it	it	PRON
bam-7594	68	24	is	be	AUX
bam-7594	68	25	increasing	increase	VERB
bam-7594	68	26	among	among	ADP
bam-7594	68	27	patients	patient	NOUN
bam-7594	68	28	.	.	PUNCT
bam-7594	69	1	by	by	ADP
bam-7594	69	2	identifying	identify	VERB
bam-7594	69	3	the	the	DET
bam-7594	69	4	pattern	pattern	NOUN
bam-7594	69	5	of	of	ADP
bam-7594	69	6	antibiotic	antibiotic	ADJ
bam-7594	69	7	resistance	resistance	NOUN
bam-7594	69	8	,	,	PUNCT
bam-7594	69	9	suggestions	suggestion	NOUN
bam-7594	69	10	can	can	AUX
bam-7594	69	11	be	be	AUX
bam-7594	69	12	made	make	VERB
bam-7594	69	13	on	on	ADP
bam-7594	69	14	how	how	SCONJ
bam-7594	69	15	antibiotics	antibiotic	NOUN
bam-7594	69	16	are	be	AUX
bam-7594	69	17	administered	administer	VERB
bam-7594	69	18	,	,	PUNCT
bam-7594	69	19	so	so	ADV
bam-7594	69	20	the	the	DET
bam-7594	69	21	study	study	NOUN
bam-7594	69	22	was	be	AUX
bam-7594	69	23	designed	design	VERB
bam-7594	69	24	to	to	PART
bam-7594	69	25	assess	assess	VERB
bam-7594	69	26	the	the	DET
bam-7594	69	27	changes	change	NOUN
bam-7594	69	28	in	in	ADP
bam-7594	69	29	antibiotic	antibiotic	ADJ
bam-7594	69	30	resistance	resistance	NOUN
bam-7594	69	31	pattern	pattern	NOUN
bam-7594	69	32	among	among	ADP
bam-7594	69	33	microorganisms	microorganism	NOUN
bam-7594	69	34	involved	involve	VERB
bam-7594	69	35	in	in	ADP
bam-7594	69	36	nosocomial	nosocomial	ADJ
bam-7594	69	37	infections	infection	NOUN
bam-7594	69	38	.	.	PUNCT
bam-7594	70	1	microorganisms	microorganism	NOUN
bam-7594	70	2	had	have	VERB
bam-7594	70	3	significant	significant	ADJ
bam-7594	70	4	variation	variation	NOUN
bam-7594	70	5	(	(	PUNCT
bam-7594	70	6	p	p	NOUN
bam-7594	70	7	=	=	NOUN
bam-7594	70	8	0.024	0.024	NUM
bam-7594	70	9	)	)	PUNCT
bam-7594	70	10	.	.	PUNCT
bam-7594	71	1	the	the	DET
bam-7594	71	2	gram	gram	NOUN
bam-7594	71	3	-	-	PUNCT
bam-7594	71	4	negative	negative	ADJ
bam-7594	71	5	bacilli	bacilli	NOUN
bam-7594	71	6	have	have	AUX
bam-7594	71	7	shown	show	VERB
bam-7594	71	8	an	an	DET
bam-7594	71	9	table	table	NOUN
bam-7594	71	10	2	2	NUM
bam-7594	71	11	.	.	PUNCT
bam-7594	71	12	pattern	pattern	NOUN
bam-7594	71	13	of	of	ADP
bam-7594	71	14	antibiotic	antibiotic	ADJ
bam-7594	71	15	resistance	resistance	NOUN
bam-7594	71	16	based	base	VERB
bam-7594	71	17	on	on	ADP
bam-7594	71	18	age	age	NOUN
bam-7594	71	19	of	of	ADP
bam-7594	71	20	patients	patient	NOUN
bam-7594	71	21	year	year	VERB
bam-7594	71	22	antibiotic	antibiotic	ADJ
bam-7594	71	23	resistance	resistance	NOUN
bam-7594	71	24	2013	2013	NUM
bam-7594	71	25	age	age	NOUN
bam-7594	71	26	was	be	AUX
bam-7594	71	27	not	not	PART
bam-7594	71	28	associated	associate	VERB
bam-7594	71	29	with	with	ADP
bam-7594	71	30	any	any	DET
bam-7594	71	31	antibiotic	antibiotic	ADJ
bam-7594	71	32	resistance	resistance	NOUN
bam-7594	71	33	(	(	PUNCT
bam-7594	71	34	p	p	X
bam-7594	71	35	>	>	X
bam-7594	71	36	0.05	0.05	NUM
bam-7594	71	37	)	)	PUNCT
bam-7594	71	38	.	.	PUNCT
bam-7594	72	1	2014	2014	NUM
bam-7594	72	2	senior	senior	ADJ
bam-7594	72	3	age	age	NOUN
bam-7594	72	4	had	have	VERB
bam-7594	72	5	a	a	DET
bam-7594	72	6	significant	significant	ADJ
bam-7594	72	7	correlation	correlation	NOUN
bam-7594	72	8	with	with	ADP
bam-7594	72	9	clindamycin	clindamycin	NOUN
bam-7594	72	10	resistance	resistance	NOUN
bam-7594	72	11	(	(	PUNCT
bam-7594	72	12	p	p	X
bam-7594	72	13	=	=	NOUN
bam-7594	72	14	0.044	0.044	NUM
bam-7594	72	15	)	)	PUNCT
bam-7594	72	16	.	.	PUNCT
bam-7594	73	1	2015	2015	NUM
bam-7594	73	2	the	the	DET
bam-7594	73	3	higher	high	ADJ
bam-7594	73	4	age	age	NOUN
bam-7594	73	5	group	group	NOUN
bam-7594	73	6	had	have	VERB
bam-7594	73	7	a	a	DET
bam-7594	73	8	significant	significant	ADJ
bam-7594	73	9	association	association	NOUN
bam-7594	73	10	with	with	ADP
bam-7594	73	11	resistance	resistance	NOUN
bam-7594	73	12	to	to	ADP
bam-7594	73	13	gentamicin	gentamicin	NOUN
bam-7594	73	14	(	(	PUNCT
bam-7594	73	15	p	p	NOUN
bam-7594	73	16	=	=	NOUN
bam-7594	73	17	0.018	0.018	NUM
bam-7594	73	18	)	)	PUNCT
bam-7594	73	19	and	and	CCONJ
bam-7594	73	20	the	the	DET
bam-7594	73	21	age	age	NOUN
bam-7594	73	22	was	be	AUX
bam-7594	73	23	significantly	significantly	ADV
bam-7594	73	24	correlated	correlate	VERB
bam-7594	73	25	with	with	ADP
bam-7594	73	26	clindamycin	clindamycin	NOUN
bam-7594	73	27	resistance	resistance	NOUN
bam-7594	73	28	(	(	PUNCT
bam-7594	73	29	p	p	NOUN
bam-7594	73	30	=	=	NOUN
bam-7594	73	31	0.034	0.034	NUM
bam-7594	73	32	)	)	PUNCT
bam-7594	73	33	.	.	PUNCT
bam-7594	74	1	*	*	PUNCT
bam-7594	74	2	*	*	PUNCT
bam-7594	74	3	*	*	PUNCT
bam-7594	74	4	*	*	PUNCT
bam-7594	74	5	*	*	PUNCT
bam-7594	74	6	*	*	PUNCT
bam-7594	74	7	*	*	PUNCT
bam-7594	74	8	*	*	PUNCT
bam-7594	74	9	*	*	PUNCT
bam-7594	74	10	*	*	PUNCT
bam-7594	74	11	*	*	PUNCT
bam-7594	74	12	*	*	PUNCT
bam-7594	74	13	*	*	PUNCT
bam-7594	74	14	*	*	PUNCT
bam-7594	74	15	*	*	PUNCT
bam-7594	74	16	*	*	PUNCT
bam-7594	74	17	*	*	PUNCT
bam-7594	74	18	*	*	PUNCT
bam-7594	74	19	*	*	PUNCT
bam-7594	74	20	*	*	PUNCT
bam-7594	74	21	*	*	PUNCT
bam-7594	74	22	*	*	PUNCT
bam-7594	74	23	*	*	PUNCT
bam-7594	74	24	*	*	PUNCT
bam-7594	74	25	*	*	PUNCT
bam-7594	74	26	*	*	PUNCT
bam-7594	74	27	*	*	PUNCT
bam-7594	74	28	*	*	PUNCT
bam-7594	74	29	*	*	PUNCT
bam-7594	74	30	*	*	PUNCT
bam-7594	74	31	*	*	PUNCT
bam-7594	74	32	*	*	PUNCT
bam-7594	74	33	*	*	PUNCT
bam-7594	74	34	*	*	PUNCT
bam-7594	74	35	table	table	NOUN
bam-7594	74	36	3	3	NUM
bam-7594	74	37	.	.	PUNCT
bam-7594	75	1	change	change	NOUN
bam-7594	75	2	in	in	ADP
bam-7594	75	3	the	the	DET
bam-7594	75	4	pattern	pattern	NOUN
bam-7594	75	5	of	of	ADP
bam-7594	75	6	antibiotic	antibiotic	ADJ
bam-7594	75	7	resistance	resistance	NOUN
bam-7594	75	8	based	base	VERB
bam-7594	75	9	on	on	ADP
bam-7594	75	10	gender	gender	NOUN
bam-7594	75	11	of	of	ADP
bam-7594	75	12	patients	patient	NOUN
bam-7594	75	13	year	year	VERB
bam-7594	75	14	antibiotic	antibiotic	ADJ
bam-7594	75	15	resistance	resistance	NOUN
bam-7594	75	16	2013	2013	NUM
bam-7594	75	17	female	female	ADJ
bam-7594	75	18	gender	gender	NOUN
bam-7594	75	19	was	be	AUX
bam-7594	75	20	associated	associate	VERB
bam-7594	75	21	with	with	ADP
bam-7594	75	22	antimicrobial	antimicrobial	ADJ
bam-7594	75	23	resistance	resistance	NOUN
bam-7594	75	24	to	to	ADP
bam-7594	75	25	amikacin	amikacin	PROPN
bam-7594	75	26	(	(	PUNCT
bam-7594	75	27	p	p	X
bam-7594	75	28	=	=	NOUN
bam-7594	75	29	0.049	0.049	NUM
bam-7594	75	30	)	)	PUNCT
bam-7594	75	31	.	.	PUNCT
bam-7594	76	1	2014	2014	NUM
bam-7594	76	2	male	male	ADJ
bam-7594	76	3	sex	sex	NOUN
bam-7594	76	4	was	be	AUX
bam-7594	76	5	associated	associate	VERB
bam-7594	76	6	with	with	ADP
bam-7594	76	7	antimicrobial	antimicrobial	ADJ
bam-7594	76	8	resistance	resistance	NOUN
bam-7594	76	9	to	to	ADP
bam-7594	76	10	levofloxacin	levofloxacin	PROPN
bam-7594	76	11	(	(	PUNCT
bam-7594	76	12	p	p	X
bam-7594	76	13	=	=	NOUN
bam-7594	76	14	0.012	0.012	NUM
bam-7594	76	15	)	)	PUNCT
bam-7594	76	16	.	.	PUNCT
bam-7594	77	1	2015	2015	NUM
bam-7594	77	2	gender	gender	NOUN
bam-7594	77	3	was	be	AUX
bam-7594	77	4	not	not	PART
bam-7594	77	5	associated	associate	VERB
bam-7594	77	6	with	with	ADP
bam-7594	77	7	any	any	DET
bam-7594	77	8	antibiotic	antibiotic	ADJ
bam-7594	77	9	resistance	resistance	NOUN
bam-7594	77	10	(	(	PUNCT
bam-7594	77	11	p	p	X
bam-7594	77	12	>	>	X
bam-7594	77	13	0.05	0.05	NUM
bam-7594	77	14	)	)	PUNCT
bam-7594	77	15	.	.	PUNCT
bam-7594	78	1	non	non	PROPN
bam-7594	78	2	co	co	PROPN
bam-7594	78	3	mmerc	mmerc	PROPN
bam-7594	78	4	ial	ial	PROPN
bam-7594	78	5	us	us	PROPN
bam-7594	78	6	e	e	NOUN
bam-7594	78	7	o	o	NOUN
bam-7594	78	8	nly	nly	ADV
bam-7594	78	9	antibiotic	antibiotic	ADJ
bam-7594	78	10	resistance	resistance	NOUN
bam-7594	78	11	of	of	ADP
bam-7594	78	12	nosocomial	nosocomial	ADJ
bam-7594	78	13	infections	infection	NOUN
bam-7594	78	14	eur	eur	PROPN
bam-7594	78	15	j	j	PROPN
bam-7594	78	16	transl	transl	PROPN
bam-7594	78	17	myol	myol	ADV
bam-7594	78	18	28	28	NUM
bam-7594	78	19	(	(	PUNCT
bam-7594	78	20	3	3	NUM
bam-7594	78	21	):	):	PUNCT
bam-7594	78	22	304	304	NUM
bam-7594	78	23	-	-	SYM
bam-7594	78	24	308	308	NUM
bam-7594	78	25	,	,	PUNCT
bam-7594	78	26	2018	2018	NUM
bam-7594	78	27	307	307	NUM
bam-7594	78	28	increased	increase	VERB
bam-7594	78	29	level	level	NOUN
bam-7594	78	30	of	of	ADP
bam-7594	78	31	resistance	resistance	NOUN
bam-7594	78	32	,	,	PUNCT
bam-7594	78	33	while	while	SCONJ
bam-7594	78	34	the	the	DET
bam-7594	78	35	gram	gram	PROPN
bam-7594	78	36	positive	positive	ADJ
bam-7594	78	37	cocci	cocci	NOUN
bam-7594	78	38	had	have	VERB
bam-7594	78	39	less	less	ADJ
bam-7594	78	40	resistance	resistance	NOUN
bam-7594	78	41	.	.	PUNCT
bam-7594	79	1	the	the	DET
bam-7594	79	2	antibiotic	antibiotic	ADJ
bam-7594	79	3	resistance	resistance	NOUN
bam-7594	79	4	was	be	AUX
bam-7594	79	5	increased	increase	VERB
bam-7594	79	6	for	for	ADP
bam-7594	79	7	ampicillin	ampicillin	NOUN
bam-7594	79	8	/	/	SYM
bam-7594	79	9	sulbactam	sulbactam	NOUN
bam-7594	79	10	,	,	PUNCT
bam-7594	79	11	piperacillin	piperacillin	NOUN
bam-7594	79	12	/	/	SYM
bam-7594	79	13	tazoactam	tazoactam	PROPN
bam-7594	79	14	,	,	PUNCT
bam-7594	79	15	ceftriaxone	ceftriaxone	PROPN
bam-7594	79	16	,	,	PUNCT
bam-7594	79	17	ceftazidime	ceftazidime	NOUN
bam-7594	79	18	,	,	PUNCT
bam-7594	79	19	cefepime	cefepime	ADV
bam-7594	79	20	,	,	PUNCT
bam-7594	79	21	meropenem	meropenem	PROPN
bam-7594	79	22	,	,	PUNCT
bam-7594	79	23	gentamicin	gentamicin	NOUN
bam-7594	79	24	,	,	PUNCT
bam-7594	79	25	amikacin	amikacin	PROPN
bam-7594	79	26	,	,	PUNCT
bam-7594	79	27	ciprofloxacine	ciprofloxacine	ADJ
bam-7594	79	28	,	,	PUNCT
bam-7594	79	29	levofloxacine	levofloxacine	NOUN
bam-7594	79	30	,	,	PUNCT
bam-7594	79	31	nitrofurantoin	nitrofurantoin	NOUN
bam-7594	79	32	,	,	PUNCT
bam-7594	79	33	and	and	CCONJ
bam-7594	79	34	ampicilline	ampicilline	NOUN
bam-7594	79	35	.	.	PUNCT
bam-7594	80	1	however	however	ADV
bam-7594	80	2	,	,	PUNCT
bam-7594	80	3	it	it	PRON
bam-7594	80	4	was	be	AUX
bam-7594	80	5	decreased	decrease	VERB
bam-7594	80	6	for	for	ADP
bam-7594	80	7	colistin	colistin	NOUN
bam-7594	80	8	.	.	PUNCT
bam-7594	81	1	behzadnia	behzadnia	PROPN
bam-7594	81	2	et	et	PROPN
bam-7594	81	3	al	al	PROPN
bam-7594	81	4	.	.	PROPN
bam-7594	82	1	2014,7	2014,7	PROPN
bam-7594	82	2	evaluated	evaluate	VERB
bam-7594	82	3	the	the	DET
bam-7594	82	4	nosocomial	nosocomial	ADJ
bam-7594	82	5	infections	infection	NOUN
bam-7594	82	6	in	in	ADP
bam-7594	82	7	children	child	NOUN
bam-7594	82	8	in	in	ADP
bam-7594	82	9	north	north	NOUN
bam-7594	82	10	of	of	ADP
bam-7594	82	11	iran	iran	PROPN
bam-7594	82	12	for	for	ADP
bam-7594	82	13	identifying	identify	VERB
bam-7594	82	14	the	the	DET
bam-7594	82	15	antibiotic	antibiotic	ADJ
bam-7594	82	16	sensitivity	sensitivity	NOUN
bam-7594	82	17	of	of	ADP
bam-7594	82	18	their	their	PRON
bam-7594	82	19	causative	causative	ADJ
bam-7594	82	20	organisms	organism	NOUN
bam-7594	82	21	.	.	PUNCT
bam-7594	83	1	they	they	PRON
bam-7594	83	2	reported	report	VERB
bam-7594	83	3	that	that	SCONJ
bam-7594	83	4	all	all	DET
bam-7594	83	5	the	the	DET
bam-7594	83	6	gram	gram	NOUN
bam-7594	83	7	positive	positive	ADJ
bam-7594	83	8	and	and	CCONJ
bam-7594	83	9	negative	negative	ADJ
bam-7594	83	10	bacterial	bacterial	ADJ
bam-7594	83	11	isolates	isolate	NOUN
bam-7594	83	12	revealed	reveal	VERB
bam-7594	83	13	remarkable	remarkable	ADJ
bam-7594	83	14	resistance	resistance	NOUN
bam-7594	83	15	to	to	ADP
bam-7594	83	16	antibiotics	antibiotic	NOUN
bam-7594	83	17	.	.	PUNCT
bam-7594	84	1	moreover	moreover	ADV
bam-7594	84	2	,	,	PUNCT
bam-7594	84	3	multidrug	multidrug	NOUN
bam-7594	84	4	-	-	PUNCT
bam-7594	84	5	resistannce	resistannce	NOUN
bam-7594	84	6	of	of	ADP
bam-7594	84	7	acinetobacter	acinetobacter	ADJ
bam-7594	84	8	spp	spp	NOUN
bam-7594	84	9	.	.	PUNCT
bam-7594	84	10	was	be	AUX
bam-7594	84	11	found	find	VERB
bam-7594	84	12	by	by	ADP
bam-7594	84	13	the	the	DET
bam-7594	84	14	mentioned	mention	VERB
bam-7594	84	15	study.6	study.6	PROPN
bam-7594	84	16	pseudomonas	pseudomona	NOUN
bam-7594	84	17	spp	spp	NOUN
bam-7594	84	18	.	.	PUNCT
bam-7594	85	1	(	(	PUNCT
bam-7594	85	2	36.84	36.84	NUM
bam-7594	85	3	%	%	NOUN
bam-7594	85	4	)	)	PUNCT
bam-7594	85	5	and	and	CCONJ
bam-7594	85	6	acinetobacter	acinetobacter	ADJ
bam-7594	85	7	spp	spp	NOUN
bam-7594	85	8	.	.	PUNCT
bam-7594	86	1	(	(	PUNCT
bam-7594	86	2	28.02	28.02	NUM
bam-7594	86	3	%	%	NOUN
bam-7594	86	4	)	)	PUNCT
bam-7594	86	5	were	be	AUX
bam-7594	86	6	mostly	mostly	ADV
bam-7594	86	7	found	find	VERB
bam-7594	86	8	in	in	ADP
bam-7594	86	9	isolated	isolated	ADJ
bam-7594	86	10	samples	sample	NOUN
bam-7594	86	11	.	.	PUNCT
bam-7594	87	1	however	however	ADV
bam-7594	87	2	,	,	PUNCT
bam-7594	87	3	pseudomonas	pseudomona	NOUN
bam-7594	87	4	showed	show	VERB
bam-7594	87	5	a	a	DET
bam-7594	87	6	significant	significant	ADJ
bam-7594	87	7	decrease	decrease	NOUN
bam-7594	87	8	in	in	ADP
bam-7594	87	9	our	our	PRON
bam-7594	87	10	research	research	NOUN
bam-7594	87	11	,	,	PUNCT
bam-7594	87	12	while	while	SCONJ
bam-7594	87	13	an	an	DET
bam-7594	87	14	increase	increase	NOUN
bam-7594	87	15	in	in	ADP
bam-7594	87	16	the	the	DET
bam-7594	87	17	frequency	frequency	NOUN
bam-7594	87	18	of	of	ADP
bam-7594	87	19	acinetobacter	acinetobacter	NOUN
bam-7594	87	20	was	be	AUX
bam-7594	87	21	reported	report	VERB
bam-7594	87	22	.	.	PUNCT
bam-7594	88	1	necati	necati	PROPN
bam-7594	88	2	hakyemez	hakyemez	INTJ
bam-7594	88	3	et	et	PROPN
bam-7594	88	4	al	al	PROPN
bam-7594	88	5	.	.	PROPN
bam-7594	89	1	in	in	ADP
bam-7594	89	2	turkey	turkey	NOUN
bam-7594	89	3	assessed	assess	VERB
bam-7594	89	4	nosocomial	nosocomial	ADJ
bam-7594	89	5	a.	a.	NOUN
bam-7594	89	6	baumannii	baumannii	ADJ
bam-7594	89	7	antibiotic	antibiotic	ADJ
bam-7594	89	8	resistance	resistance	NOUN
bam-7594	89	9	in	in	ADP
bam-7594	89	10	patients	patient	NOUN
bam-7594	89	11	suffering	suffer	VERB
bam-7594	89	12	from	from	ADP
bam-7594	89	13	nosocomial	nosocomial	ADJ
bam-7594	89	14	infections.8	infections.8	PROPN
bam-7594	89	15	the	the	DET
bam-7594	89	16	most	most	ADV
bam-7594	89	17	effective	effective	ADJ
bam-7594	89	18	antibiotics	antibiotic	NOUN
bam-7594	89	19	in	in	ADP
bam-7594	89	20	isolated	isolated	ADJ
bam-7594	89	21	strains	strain	NOUN
bam-7594	89	22	included	include	VERB
bam-7594	89	23	imipenem	imipenem	PROPN
bam-7594	89	24	,	,	PUNCT
bam-7594	89	25	meropenem	meropenem	PROPN
bam-7594	89	26	,	,	PUNCT
bam-7594	89	27	colistin	colistin	NOUN
bam-7594	89	28	and	and	CCONJ
bam-7594	89	29	tigecycline	tigecycline	NOUN
bam-7594	89	30	,	,	PUNCT
bam-7594	89	31	as	as	SCONJ
bam-7594	89	32	reported	report	VERB
bam-7594	89	33	previously	previously	ADV
bam-7594	89	34	by	by	ADP
bam-7594	89	35	necati	necati	ADJ
bam-7594	89	36	hakyemez	hakyemez	PROPN
bam-7594	89	37	et	et	PROPN
bam-7594	89	38	al.8	al.8	PROPN
bam-7594	89	39	however	however	ADV
bam-7594	89	40	,	,	PUNCT
bam-7594	89	41	they	they	PRON
bam-7594	89	42	showed	show	VERB
bam-7594	89	43	that	that	SCONJ
bam-7594	89	44	the	the	DET
bam-7594	89	45	antibiotic	antibiotic	ADJ
bam-7594	89	46	resistance	resistance	NOUN
bam-7594	89	47	level	level	NOUN
bam-7594	89	48	against	against	ADP
bam-7594	89	49	imipenem	imipenem	PROPN
bam-7594	89	50	and	and	CCONJ
bam-7594	89	51	meropenem	meropenem	PROPN
bam-7594	89	52	has	have	AUX
bam-7594	89	53	increased	increase	VERB
bam-7594	89	54	over	over	ADP
bam-7594	89	55	the	the	DET
bam-7594	89	56	years	year	NOUN
bam-7594	89	57	,	,	PUNCT
bam-7594	89	58	an	an	DET
bam-7594	89	59	observation	observation	NOUN
bam-7594	89	60	that	that	SCONJ
bam-7594	89	61	our	our	PRON
bam-7594	89	62	research	research	NOUN
bam-7594	89	63	findings	finding	NOUN
bam-7594	89	64	confirm	confirm	VERB
bam-7594	89	65	.	.	PUNCT
bam-7594	90	1	another	another	DET
bam-7594	90	2	study	study	NOUN
bam-7594	90	3	demonstrated	demonstrate	VERB
bam-7594	90	4	antibiotic	antibiotic	ADJ
bam-7594	90	5	-	-	PUNCT
bam-7594	90	6	resistant	resistant	ADJ
bam-7594	90	7	acinetobacter	acinetobacter	ADJ
bam-7594	90	8	baumannii	baumannii	ADJ
bam-7594	90	9	infections	infection	NOUN
bam-7594	90	10	in	in	ADP
bam-7594	90	11	another	another	DET
bam-7594	90	12	hospital	hospital	NOUN
bam-7594	90	13	in	in	ADP
bam-7594	90	14	tehran	tehran	PROPN
bam-7594	90	15	,	,	PUNCT
bam-7594	90	16	iran	iran	PROPN
bam-7594	90	17	.	.	PUNCT
bam-7594	91	1	as	as	SCONJ
bam-7594	91	2	reported	report	VERB
bam-7594	91	3	by	by	ADP
bam-7594	91	4	vahdani	vahdani	PROPN
bam-7594	91	5	et	et	PROPN
bam-7594	91	6	al,9	al,9	PROPN
bam-7594	91	7	the	the	DET
bam-7594	91	8	highest	high	ADJ
bam-7594	91	9	resistance	resistance	NOUN
bam-7594	91	10	belonged	belong	VERB
bam-7594	91	11	to	to	ADP
bam-7594	91	12	ceftazidime	ceftazidime	NOUN
bam-7594	91	13	(	(	PUNCT
bam-7594	91	14	96	96	NUM
bam-7594	91	15	%	%	NOUN
bam-7594	91	16	)	)	PUNCT
bam-7594	91	17	,	,	PUNCT
bam-7594	91	18	followed	follow	VERB
bam-7594	91	19	by	by	ADP
bam-7594	91	20	ceftizoxime	ceftizoxime	NOUN
bam-7594	91	21	(	(	PUNCT
bam-7594	91	22	95	95	NUM
bam-7594	91	23	%	%	NOUN
bam-7594	91	24	)	)	PUNCT
bam-7594	91	25	,	,	PUNCT
bam-7594	91	26	ceftriaxone	ceftriaxone	PROPN
bam-7594	91	27	(	(	PUNCT
bam-7594	91	28	93	93	NUM
bam-7594	91	29	%	%	NOUN
bam-7594	91	30	)	)	PUNCT
bam-7594	91	31	,	,	PUNCT
bam-7594	91	32	ciprofloxacin	ciprofloxacin	NOUN
bam-7594	91	33	(	(	PUNCT
bam-7594	91	34	85	85	NUM
bam-7594	91	35	%	%	NOUN
bam-7594	91	36	)	)	PUNCT
bam-7594	91	37	,	,	PUNCT
bam-7594	91	38	co	co	NOUN
bam-7594	91	39	-	-	NOUN
bam-7594	91	40	terimoxazole	terimoxazole	NOUN
bam-7594	91	41	(	(	PUNCT
bam-7594	91	42	85	85	NUM
bam-7594	91	43	%	%	NOUN
bam-7594	91	44	)	)	PUNCT
bam-7594	91	45	,	,	PUNCT
bam-7594	91	46	gentamicin	gentamicin	NOUN
bam-7594	91	47	(	(	PUNCT
bam-7594	91	48	68	68	NUM
bam-7594	91	49	%	%	NOUN
bam-7594	91	50	)	)	PUNCT
bam-7594	91	51	,	,	PUNCT
bam-7594	91	52	amikacin	amikacin	PROPN
bam-7594	91	53	(	(	PUNCT
bam-7594	91	54	58	58	NUM
bam-7594	91	55	%	%	NOUN
bam-7594	91	56	)	)	PUNCT
bam-7594	91	57	and	and	CCONJ
bam-7594	91	58	imipenem	imipenem	PROPN
bam-7594	91	59	(	(	PUNCT
bam-7594	91	60	9	9	NUM
bam-7594	91	61	%	%	NOUN
bam-7594	91	62	)	)	PUNCT
bam-7594	91	63	.	.	PUNCT
bam-7594	92	1	report	report	VERB
bam-7594	92	2	that	that	SCONJ
bam-7594	92	3	gram	gram	NOUN
bam-7594	92	4	-	-	PUNCT
bam-7594	92	5	positive	positive	ADJ
bam-7594	92	6	bacteria	bacteria	NOUN
bam-7594	92	7	,	,	PUNCT
bam-7594	92	8	in	in	ADP
bam-7594	92	9	particular	particular	ADJ
bam-7594	92	10	staphylococcus	staphylococcus	NOUN
bam-7594	92	11	aureus	aureus	NOUN
bam-7594	92	12	,	,	PUNCT
bam-7594	92	13	have	have	VERB
bam-7594	92	14	a	a	DET
bam-7594	92	15	100	100	NUM
bam-7594	92	16	-	-	PUNCT
bam-7594	92	17	percent	percent	NOUN
bam-7594	92	18	resistance	resistance	NOUN
bam-7594	92	19	to	to	ADP
bam-7594	92	20	ceftriaxone	ceftriaxone	PROPN
bam-7594	92	21	,	,	PUNCT
bam-7594	92	22	cotrimoxazole	cotrimoxazole	NOUN
bam-7594	92	23	and	and	CCONJ
bam-7594	92	24	cefotaxime	cefotaxime	NOUN
bam-7594	92	25	,	,	PUNCT
bam-7594	92	26	while	while	SCONJ
bam-7594	92	27	they	they	PRON
bam-7594	92	28	have	have	VERB
bam-7594	92	29	a	a	DET
bam-7594	92	30	high	high	ADJ
bam-7594	92	31	sensitivity	sensitivity	NOUN
bam-7594	92	32	to	to	ADP
bam-7594	92	33	vancomycin	vancomycin	PROPN
bam-7594	92	34	.	.	PUNCT
bam-7594	93	1	there	there	PRON
bam-7594	93	2	was	be	VERB
bam-7594	93	3	also	also	ADV
bam-7594	93	4	a	a	DET
bam-7594	93	5	high	high	ADJ
bam-7594	93	6	resistance	resistance	NOUN
bam-7594	93	7	among	among	ADP
bam-7594	93	8	gram	gram	NOUN
bam-7594	93	9	-	-	PUNCT
bam-7594	93	10	negative	negative	ADJ
bam-7594	93	11	bacteria	bacteria	NOUN
bam-7594	93	12	to	to	ADP
bam-7594	93	13	the	the	DET
bam-7594	93	14	antibiotics	antibiotic	NOUN
bam-7594	93	15	investigated	investigate	VERB
bam-7594	93	16	in	in	ADP
bam-7594	93	17	mentioned	mention	VERB
bam-7594	93	18	study	study	NOUN
bam-7594	93	19	,	,	PUNCT
bam-7594	93	20	including	include	VERB
bam-7594	93	21	ceftriaxone	ceftriaxone	PROPN
bam-7594	93	22	,	,	PUNCT
bam-7594	93	23	cefotaxime	cefotaxime	NOUN
bam-7594	93	24	and	and	CCONJ
bam-7594	93	25	cotrimoxazole.9	cotrimoxazole.9	NOUN
bam-7594	93	26	accordingly	accordingly	ADV
bam-7594	93	27	,	,	PUNCT
bam-7594	93	28	the	the	DET
bam-7594	93	29	frequency	frequency	NOUN
bam-7594	93	30	of	of	ADP
bam-7594	93	31	agents	agent	NOUN
bam-7594	93	32	involved	involve	VERB
bam-7594	93	33	in	in	ADP
bam-7594	93	34	nosocomial	nosocomial	ADJ
bam-7594	93	35	infections	infection	NOUN
bam-7594	93	36	will	will	AUX
bam-7594	93	37	vary	vary	VERB
bam-7594	93	38	from	from	ADP
bam-7594	93	39	region	region	NOUN
bam-7594	93	40	to	to	ADP
bam-7594	93	41	region.4,9,10	region.4,9,10	NOUN
bam-7594	93	42	.	.	PUNCT
bam-7594	94	1	in	in	ADP
bam-7594	94	2	our	our	PRON
bam-7594	94	3	study	study	NOUN
bam-7594	94	4	,	,	PUNCT
bam-7594	94	5	the	the	DET
bam-7594	94	6	type	type	NOUN
bam-7594	94	7	of	of	ADP
bam-7594	94	8	microorganism	microorganism	NOUN
bam-7594	94	9	influence	influence	NOUN
bam-7594	94	10	antibiotic	antibiotic	ADJ
bam-7594	94	11	resistance	resistance	NOUN
bam-7594	94	12	.	.	PUNCT
bam-7594	95	1	weinstein	weinstein	PROPN
bam-7594	95	2	et	et	PROPN
bam-7594	95	3	al.11	al.11	PROPN
bam-7594	95	4	in	in	ADP
bam-7594	95	5	the	the	DET
bam-7594	95	6	united	united	PROPN
bam-7594	95	7	states	states	PROPN
bam-7594	95	8	indicated	indicate	VERB
bam-7594	95	9	that	that	SCONJ
bam-7594	95	10	antibiotic	antibiotic	ADJ
bam-7594	95	11	resistance	resistance	NOUN
bam-7594	95	12	of	of	ADP
bam-7594	95	13	the	the	DET
bam-7594	95	14	causative	causative	ADJ
bam-7594	95	15	organisms	organism	NOUN
bam-7594	95	16	is	be	AUX
bam-7594	95	17	increasing	increase	VERB
bam-7594	95	18	among	among	ADP
bam-7594	95	19	the	the	DET
bam-7594	95	20	patients	patient	NOUN
bam-7594	95	21	with	with	ADP
bam-7594	95	22	nosocomial	nosocomial	ADJ
bam-7594	95	23	infections	infection	NOUN
bam-7594	95	24	,	,	PUNCT
bam-7594	95	25	specificlly	specificlly	ADV
bam-7594	95	26	for	for	ADP
bam-7594	95	27	staphylococci	staphylococci	NOUN
bam-7594	95	28	,	,	PUNCT
bam-7594	95	29	and	and	CCONJ
bam-7594	95	30	enterobacteriaceae	enterobacteriaceae	PROPN
bam-7594	95	31	(	(	PUNCT
bam-7594	95	32	pseudomonas	pseudomona	NOUN
bam-7594	95	33	aeruginosa	aeruginosa	NOUN
bam-7594	95	34	)	)	PUNCT
bam-7594	95	35	,	,	PUNCT
bam-7594	95	36	as	as	SCONJ
bam-7594	95	37	we	we	PRON
bam-7594	95	38	confirm	confirm	VERB
bam-7594	95	39	with	with	ADP
bam-7594	95	40	present	present	ADJ
bam-7594	95	41	findings	finding	NOUN
bam-7594	95	42	.	.	PUNCT
bam-7594	96	1	we	we	PRON
bam-7594	96	2	table	table	VERB
bam-7594	96	3	4	4	NUM
bam-7594	96	4	.	.	PUNCT
bam-7594	97	1	antibiotic	antibiotic	ADJ
bam-7594	97	2	resistance	resistance	NOUN
bam-7594	97	3	pattern	pattern	NOUN
bam-7594	97	4	based	base	VERB
bam-7594	97	5	on	on	ADP
bam-7594	97	6	sample	sample	NOUN
bam-7594	97	7	type	type	NOUN
bam-7594	97	8	year	year	NOUN
bam-7594	97	9	antibiotic	antibiotic	ADJ
bam-7594	97	10	resistance	resistance	NOUN
bam-7594	97	11	2013	2013	NUM
bam-7594	97	12	the	the	DET
bam-7594	97	13	blood	blood	NOUN
bam-7594	97	14	sample	sample	NOUN
bam-7594	97	15	was	be	AUX
bam-7594	97	16	associated	associate	VERB
bam-7594	97	17	with	with	ADP
bam-7594	97	18	antibiotic	antibiotic	ADJ
bam-7594	97	19	resistance	resistance	NOUN
bam-7594	97	20	to	to	ADP
bam-7594	97	21	vancomycin	vancomycin	PROPN
bam-7594	97	22	(	(	PUNCT
bam-7594	97	23	p	p	NOUN
bam-7594	97	24	=	=	NOUN
bam-7594	97	25	0.001	0.001	NUM
bam-7594	97	26	)	)	PUNCT
bam-7594	97	27	,	,	PUNCT
bam-7594	97	28	oxacillin	oxacillin	NOUN
bam-7594	97	29	(	(	PUNCT
bam-7594	97	30	p	p	NOUN
bam-7594	97	31	=	=	PROPN
bam-7594	97	32	0.021	0.021	NUM
bam-7594	97	33	)	)	PUNCT
bam-7594	97	34	,	,	PUNCT
bam-7594	97	35	ceftriaxone	ceftriaxone	NOUN
bam-7594	97	36	(	(	PUNCT
bam-7594	97	37	p	p	NOUN
bam-7594	97	38	=	=	NOUN
bam-7594	97	39	0.002	0.002	NUM
bam-7594	97	40	)	)	PUNCT
bam-7594	97	41	,	,	PUNCT
bam-7594	97	42	cefipime	cefipime	NOUN
bam-7594	97	43	(	(	PUNCT
bam-7594	97	44	p	p	NOUN
bam-7594	97	45	=	=	NOUN
bam-7594	97	46	0.013	0.013	NUM
bam-7594	97	47	)	)	PUNCT
bam-7594	97	48	,	,	PUNCT
bam-7594	97	49	linzolide	linzolide	INTJ
bam-7594	97	50	(	(	PUNCT
bam-7594	97	51	p	p	X
bam-7594	97	52	=	=	NOUN
bam-7594	97	53	0.003	0.003	NUM
bam-7594	97	54	)	)	PUNCT
bam-7594	97	55	and	and	CCONJ
bam-7594	97	56	clindamycin	clindamycin	NOUN
bam-7594	97	57	(	(	PUNCT
bam-7594	97	58	p	p	X
bam-7594	97	59	=	=	NOUN
bam-7594	97	60	0.015	0.015	NUM
bam-7594	97	61	)	)	PUNCT
bam-7594	97	62	.	.	PUNCT
bam-7594	98	1	a	a	DET
bam-7594	98	2	sample	sample	NOUN
bam-7594	98	3	of	of	ADP
bam-7594	98	4	phlegm	phlegm	NOUN
bam-7594	98	5	was	be	AUX
bam-7594	98	6	associated	associate	VERB
bam-7594	98	7	with	with	ADP
bam-7594	98	8	antibiotic	antibiotic	ADJ
bam-7594	98	9	resistance	resistance	NOUN
bam-7594	98	10	to	to	ADP
bam-7594	98	11	piperacillin	piperacillin	PROPN
bam-7594	98	12	/	/	SYM
bam-7594	98	13	tazobactam	tazobactam	NOUN
bam-7594	98	14	(	(	PUNCT
bam-7594	98	15	p	p	NOUN
bam-7594	98	16	=	=	NOUN
bam-7594	98	17	0.001	0.001	NUM
bam-7594	98	18	)	)	PUNCT
bam-7594	98	19	,	,	PUNCT
bam-7594	98	20	meropenem	meropenem	PROPN
bam-7594	98	21	(	(	PUNCT
bam-7594	98	22	p	p	NOUN
bam-7594	98	23	=	=	NOUN
bam-7594	98	24	0.001	0.001	NUM
bam-7594	98	25	)	)	PUNCT
bam-7594	98	26	,	,	PUNCT
bam-7594	98	27	amikacin	amikacin	PROPN
bam-7594	98	28	(	(	PUNCT
bam-7594	98	29	p	p	X
bam-7594	98	30	=	=	NOUN
bam-7594	98	31	0.001	0.001	NUM
bam-7594	98	32	)	)	PUNCT
bam-7594	98	33	while	while	SCONJ
bam-7594	98	34	the	the	DET
bam-7594	98	35	urine	urine	NOUN
bam-7594	98	36	sample	sample	NOUN
bam-7594	98	37	was	be	AUX
bam-7594	98	38	related	relate	VERB
bam-7594	98	39	to	to	ADP
bam-7594	98	40	antibiotic	antibiotic	ADJ
bam-7594	98	41	resistance	resistance	NOUN
bam-7594	98	42	to	to	ADP
bam-7594	98	43	nalidixic	nalidixic	ADJ
bam-7594	98	44	acid	acid	NOUN
bam-7594	98	45	(	(	PUNCT
bam-7594	98	46	p	p	NOUN
bam-7594	98	47	=	=	NOUN
bam-7594	98	48	0.001	0.001	NUM
bam-7594	98	49	)	)	PUNCT
bam-7594	98	50	.	.	PUNCT
bam-7594	99	1	2014	2014	NUM
bam-7594	99	2	blood	blood	NOUN
bam-7594	99	3	samples	sample	NOUN
bam-7594	99	4	were	be	AUX
bam-7594	99	5	correlated	correlate	VERB
bam-7594	99	6	with	with	ADP
bam-7594	99	7	antibiotic	antibiotic	ADJ
bam-7594	99	8	resistance	resistance	NOUN
bam-7594	99	9	to	to	ADP
bam-7594	99	10	ceftriaxone	ceftriaxone	PROPN
bam-7594	99	11	(	(	PUNCT
bam-7594	99	12	p	p	NOUN
bam-7594	99	13	=	=	NOUN
bam-7594	99	14	0.001	0.001	NUM
bam-7594	99	15	)	)	PUNCT
bam-7594	99	16	,	,	PUNCT
bam-7594	99	17	cefepime	cefepime	NOUN
bam-7594	99	18	(	(	PUNCT
bam-7594	99	19	p	p	NOUN
bam-7594	99	20	=	=	NOUN
bam-7594	99	21	0.001	0.001	NUM
bam-7594	99	22	)	)	PUNCT
bam-7594	99	23	,	,	PUNCT
bam-7594	99	24	meropenem	meropenem	PROPN
bam-7594	100	1	(	(	PUNCT
bam-7594	100	2	p	p	NOUN
bam-7594	100	3	=	=	NOUN
bam-7594	100	4	0.001	0.001	NUM
bam-7594	100	5	)	)	PUNCT
bam-7594	100	6	,	,	PUNCT
bam-7594	100	7	amikacin	amikacin	PROPN
bam-7594	100	8	(	(	PUNCT
bam-7594	100	9	p	p	X
bam-7594	100	10	=	=	NOUN
bam-7594	100	11	0.001	0.001	NUM
bam-7594	100	12	)	)	PUNCT
bam-7594	100	13	,	,	PUNCT
bam-7594	100	14	and	and	CCONJ
bam-7594	100	15	colistin	colistin	VERB
bam-7594	100	16	(	(	PUNCT
bam-7594	100	17	p	p	NOUN
bam-7594	100	18	=	=	NOUN
bam-7594	100	19	0.040	0.040	NUM
bam-7594	100	20	)	)	PUNCT
bam-7594	100	21	.	.	PUNCT
bam-7594	101	1	the	the	DET
bam-7594	101	2	association	association	NOUN
bam-7594	101	3	of	of	ADP
bam-7594	101	4	sputum	sputum	PROPN
bam-7594	101	5	samples	sample	NOUN
bam-7594	101	6	with	with	ADP
bam-7594	101	7	antibiotic	antibiotic	ADJ
bam-7594	101	8	resistance	resistance	NOUN
bam-7594	101	9	was	be	AUX
bam-7594	101	10	detected	detect	VERB
bam-7594	101	11	in	in	ADP
bam-7594	101	12	a	a	DET
bam-7594	101	13	number	number	NOUN
bam-7594	101	14	of	of	ADP
bam-7594	101	15	bacteria	bacteria	NOUN
bam-7594	101	16	including	include	VERB
bam-7594	101	17	piperacillin	piperacillin	PROPN
bam-7594	101	18	/	/	SYM
bam-7594	101	19	tazobactam	tazobactam	NOUN
bam-7594	101	20	(	(	PUNCT
bam-7594	101	21	p	p	NOUN
bam-7594	101	22	=	=	NOUN
bam-7594	101	23	0.001	0.001	NUM
bam-7594	101	24	)	)	PUNCT
bam-7594	101	25	,	,	PUNCT
bam-7594	101	26	ceftazidime	ceftazidime	NOUN
bam-7594	101	27	(	(	PUNCT
bam-7594	101	28	p	p	X
bam-7594	101	29	=	=	NOUN
bam-7594	101	30	0.043	0.043	NUM
bam-7594	101	31	)	)	PUNCT
bam-7594	101	32	,	,	PUNCT
bam-7594	101	33	imipenem	imipenem	PROPN
bam-7594	101	34	(	(	PUNCT
bam-7594	101	35	p	p	NOUN
bam-7594	101	36	=	=	NOUN
bam-7594	101	37	0.001	0.001	NUM
bam-7594	101	38	)	)	PUNCT
bam-7594	101	39	,	,	PUNCT
bam-7594	101	40	gentamicin	gentamicin	NOUN
bam-7594	101	41	(	(	PUNCT
bam-7594	101	42	p	p	NOUN
bam-7594	101	43	=	=	NOUN
bam-7594	101	44	0.001	0.001	NUM
bam-7594	101	45	)	)	PUNCT
bam-7594	101	46	,	,	PUNCT
bam-7594	101	47	and	and	CCONJ
bam-7594	101	48	ciprofloxacin	ciprofloxacin	NOUN
bam-7594	101	49	(	(	PUNCT
bam-7594	101	50	p	p	NOUN
bam-7594	101	51	=	=	NOUN
bam-7594	101	52	0.001	0.001	NUM
bam-7594	101	53	)	)	PUNCT
bam-7594	101	54	.	.	PUNCT
bam-7594	102	1	2015	2015	NUM
bam-7594	102	2	the	the	DET
bam-7594	102	3	association	association	NOUN
bam-7594	102	4	of	of	ADP
bam-7594	102	5	blood	blood	NOUN
bam-7594	102	6	samples	sample	NOUN
bam-7594	102	7	with	with	ADP
bam-7594	102	8	antibiotic	antibiotic	ADJ
bam-7594	102	9	resistance	resistance	NOUN
bam-7594	102	10	was	be	AUX
bam-7594	102	11	observed	observe	VERB
bam-7594	102	12	only	only	ADV
bam-7594	102	13	in	in	ADP
bam-7594	102	14	ceftriaxone	ceftriaxone	PROPN
bam-7594	102	15	(	(	PUNCT
bam-7594	102	16	p	p	NOUN
bam-7594	102	17	=	=	NOUN
bam-7594	102	18	0.001	0.001	NUM
bam-7594	102	19	)	)	PUNCT
bam-7594	102	20	and	and	CCONJ
bam-7594	102	21	cefepime	cefepime	NOUN
bam-7594	102	22	(	(	PUNCT
bam-7594	102	23	p	p	NOUN
bam-7594	102	24	=	=	NOUN
bam-7594	102	25	0.001	0.001	NUM
bam-7594	102	26	)	)	PUNCT
bam-7594	102	27	.	.	PUNCT
bam-7594	103	1	furthermore	furthermore	ADV
bam-7594	103	2	,	,	PUNCT
bam-7594	103	3	the	the	DET
bam-7594	103	4	sputum	sputum	NOUN
bam-7594	103	5	samples	sample	NOUN
bam-7594	103	6	had	have	VERB
bam-7594	103	7	a	a	DET
bam-7594	103	8	significant	significant	ADJ
bam-7594	103	9	relationship	relationship	NOUN
bam-7594	103	10	with	with	ADP
bam-7594	103	11	antibiotics	antibiotic	NOUN
bam-7594	103	12	in	in	ADP
bam-7594	103	13	terms	term	NOUN
bam-7594	103	14	of	of	ADP
bam-7594	103	15	drug	drug	NOUN
bam-7594	103	16	resistance	resistance	NOUN
bam-7594	103	17	including	include	VERB
bam-7594	103	18	piperacillin	piperacillin	PROPN
bam-7594	103	19	/	/	SYM
bam-7594	103	20	tazobactam	tazobactam	NOUN
bam-7594	103	21	(	(	PUNCT
bam-7594	103	22	p	p	NOUN
bam-7594	103	23	=	=	NOUN
bam-7594	103	24	0.001	0.001	NUM
bam-7594	103	25	)	)	PUNCT
bam-7594	103	26	,	,	PUNCT
bam-7594	103	27	imipenem	imipenem	PROPN
bam-7594	103	28	(	(	PUNCT
bam-7594	103	29	p	p	NOUN
bam-7594	103	30	=	=	NOUN
bam-7594	103	31	0.001	0.001	NUM
bam-7594	103	32	)	)	PUNCT
bam-7594	103	33	,	,	PUNCT
bam-7594	103	34	moropenem	moropenem	X
bam-7594	103	35	(	(	PUNCT
bam-7594	103	36	p	p	NOUN
bam-7594	103	37	=	=	NOUN
bam-7594	103	38	0.001	0.001	NUM
bam-7594	103	39	)	)	PUNCT
bam-7594	103	40	and	and	CCONJ
bam-7594	103	41	amikacin	amikacin	PROPN
bam-7594	103	42	(	(	PUNCT
bam-7594	103	43	p	p	NOUN
bam-7594	103	44	=	=	NOUN
bam-7594	103	45	0.001	0.001	NUM
bam-7594	103	46	)	)	PUNCT
bam-7594	103	47	ciprofloxacin	ciprofloxacin	NOUN
bam-7594	103	48	(	(	PUNCT
bam-7594	103	49	pp	pp	ADP
bam-7594	103	50	=	=	SYM
bam-7594	103	51	0.027	0.027	NUM
bam-7594	103	52	)	)	PUNCT
bam-7594	103	53	and	and	CCONJ
bam-7594	103	54	levofloxacin	levofloxacin	NOUN
bam-7594	103	55	(	(	PUNCT
bam-7594	103	56	p	p	X
bam-7594	103	57	=	=	NOUN
bam-7594	103	58	0.016	0.016	NUM
bam-7594	103	59	)	)	PUNCT
bam-7594	103	60	.	.	PUNCT
bam-7594	104	1	while	while	SCONJ
bam-7594	104	2	urine	urine	NOUN
bam-7594	104	3	specimens	specimen	NOUN
bam-7594	104	4	were	be	AUX
bam-7594	104	5	associated	associate	VERB
bam-7594	104	6	with	with	ADP
bam-7594	104	7	antibiotic	antibiotic	ADJ
bam-7594	104	8	resistance	resistance	NOUN
bam-7594	104	9	to	to	ADP
bam-7594	104	10	co	co	NOUN
bam-7594	104	11	-	-	NOUN
bam-7594	104	12	trimoxazole	trimoxazole	ADJ
bam-7594	104	13	(	(	PUNCT
bam-7594	104	14	p	p	NOUN
bam-7594	104	15	=	=	NOUN
bam-7594	104	16	0.005	0.005	NUM
bam-7594	104	17	)	)	PUNCT
bam-7594	105	1	*	*	PUNCT
bam-7594	106	1	*	*	PUNCT
bam-7594	106	2	*	*	PUNCT
bam-7594	106	3	*	*	PUNCT
bam-7594	106	4	*	*	PUNCT
bam-7594	106	5	*	*	PUNCT
bam-7594	106	6	*	*	PUNCT
bam-7594	106	7	*	*	PUNCT
bam-7594	106	8	*	*	PUNCT
bam-7594	106	9	*	*	PUNCT
bam-7594	106	10	*	*	PUNCT
bam-7594	106	11	*	*	PUNCT
bam-7594	106	12	*	*	PUNCT
bam-7594	106	13	*	*	PUNCT
bam-7594	106	14	*	*	PUNCT
bam-7594	106	15	*	*	PUNCT
bam-7594	106	16	*	*	PUNCT
bam-7594	106	17	*	*	PUNCT
bam-7594	106	18	*	*	PUNCT
bam-7594	106	19	*	*	PUNCT
bam-7594	106	20	*	*	PUNCT
bam-7594	106	21	*	*	PUNCT
bam-7594	106	22	*	*	PUNCT
bam-7594	106	23	*	*	PUNCT
bam-7594	106	24	*	*	PUNCT
bam-7594	106	25	*	*	PUNCT
bam-7594	106	26	*	*	PUNCT
bam-7594	106	27	*	*	PUNCT
bam-7594	106	28	*	*	PUNCT
bam-7594	106	29	*	*	PUNCT
bam-7594	106	30	*	*	PUNCT
bam-7594	106	31	*	*	PUNCT
bam-7594	106	32	*	*	PUNCT
bam-7594	106	33	*	*	PUNCT
bam-7594	106	34	table	table	NOUN
bam-7594	106	35	5	5	NUM
bam-7594	106	36	.	.	PUNCT
bam-7594	107	1	change	change	NOUN
bam-7594	107	2	in	in	ADP
bam-7594	107	3	antibiotic	antibiotic	ADJ
bam-7594	107	4	resistance	resistance	NOUN
bam-7594	107	5	patterns	pattern	NOUN
bam-7594	107	6	based	base	VERB
bam-7594	107	7	on	on	ADP
bam-7594	107	8	the	the	DET
bam-7594	107	9	type	type	NOUN
bam-7594	107	10	of	of	ADP
bam-7594	107	11	agents	agent	NOUN
bam-7594	107	12	year	year	NOUN
bam-7594	107	13	antibiotic	antibiotic	ADJ
bam-7594	107	14	resistance	resistance	NOUN
bam-7594	107	15	2013	2013	NUM
bam-7594	107	16	there	there	PRON
bam-7594	107	17	was	be	VERB
bam-7594	107	18	correlation	correlation	NOUN
bam-7594	107	19	between	between	ADP
bam-7594	107	20	agents	agent	NOUN
bam-7594	107	21	and	and	CCONJ
bam-7594	107	22	antibiotic	antibiotic	ADJ
bam-7594	107	23	resistance	resistance	NOUN
bam-7594	107	24	for	for	ADP
bam-7594	107	25	all	all	DET
bam-7594	107	26	antibiotics	antibiotic	NOUN
bam-7594	107	27	(	(	PUNCT
bam-7594	107	28	p	p	X
bam-7594	107	29	<	<	X
bam-7594	107	30	0.05	0.05	NUM
bam-7594	107	31	)	)	PUNCT
bam-7594	107	32	other	other	ADJ
bam-7594	107	33	than	than	ADP
bam-7594	107	34	vancomycin	vancomycin	PROPN
bam-7594	107	35	,	,	PUNCT
bam-7594	107	36	linezolid	linezolid	NOUN
bam-7594	107	37	and	and	CCONJ
bam-7594	107	38	cotrimoxazole	cotrimoxazole	NOUN
bam-7594	107	39	2014	2014	NUM
bam-7594	107	40	there	there	PRON
bam-7594	107	41	was	be	VERB
bam-7594	107	42	a	a	DET
bam-7594	107	43	correlation	correlation	NOUN
bam-7594	107	44	between	between	ADP
bam-7594	107	45	agents	agent	NOUN
bam-7594	107	46	and	and	CCONJ
bam-7594	107	47	antibiotic	antibiotic	ADJ
bam-7594	107	48	resistance	resistance	NOUN
bam-7594	107	49	for	for	ADP
bam-7594	107	50	all	all	DET
bam-7594	107	51	antibiotics	antibiotic	NOUN
bam-7594	107	52	(	(	PUNCT
bam-7594	107	53	p	p	X
bam-7594	107	54	<	<	X
bam-7594	107	55	0.05	0.05	NUM
bam-7594	107	56	)	)	PUNCT
bam-7594	107	57	.	.	PUNCT
bam-7594	108	1	2015	2015	NUM
bam-7594	108	2	a	a	DET
bam-7594	108	3	significant	significant	ADJ
bam-7594	108	4	association	association	NOUN
bam-7594	108	5	was	be	AUX
bam-7594	108	6	found	find	VERB
bam-7594	108	7	between	between	ADP
bam-7594	108	8	agents	agent	NOUN
bam-7594	108	9	and	and	CCONJ
bam-7594	108	10	antibiotic	antibiotic	ADJ
bam-7594	108	11	resistance	resistance	NOUN
bam-7594	108	12	in	in	ADP
bam-7594	108	13	all	all	DET
bam-7594	108	14	antibiotics	antibiotic	NOUN
bam-7594	108	15	(	(	PUNCT
bam-7594	108	16	p	p	X
bam-7594	108	17	<	<	X
bam-7594	108	18	0.05	0.05	NUM
bam-7594	108	19	)	)	PUNCT
bam-7594	108	20	with	with	ADP
bam-7594	108	21	the	the	DET
bam-7594	108	22	exception	exception	NOUN
bam-7594	108	23	of	of	ADP
bam-7594	108	24	oxacillin	oxacillin	PROPN
bam-7594	108	25	,	,	PUNCT
bam-7594	108	26	cefazolin	cefazolin	PROPN
bam-7594	108	27	,	,	PUNCT
bam-7594	108	28	cefoxitin	cefoxitin	NOUN
bam-7594	108	29	,	,	PUNCT
bam-7594	108	30	nalidixic	nalidixic	ADJ
bam-7594	108	31	acid	acid	NOUN
bam-7594	108	32	,	,	PUNCT
bam-7594	108	33	nitrofurantoin	nitrofurantoin	NOUN
bam-7594	108	34	,	,	PUNCT
bam-7594	108	35	rifampicin	rifampicin	VERB
bam-7594	108	36	and	and	CCONJ
bam-7594	108	37	clindamycin	clindamycin	NOUN
bam-7594	108	38	non	non	ADJ
bam-7594	108	39	co	co	X
bam-7594	108	40	mmerc	mmerc	PROPN
bam-7594	108	41	ial	ial	PROPN
bam-7594	108	42	us	us	PROPN
bam-7594	108	43	e	e	NOUN
bam-7594	108	44	o	o	PROPN
bam-7594	108	45	nly	nly	ADV
bam-7594	108	46	https://www.ncbi.nlm.nih.gov/pubmed/?term=behzadnia%20s%5bauthor%5d&cauthor=true&cauthor_uid=24719744	https://www.ncbi.nlm.nih.gov/pubmed/?term=behzadnia%20s%5bauthor%5d&cauthor=true&cauthor_uid=24719744	X
bam-7594	108	47	https://www.ncbi.nlm.nih.gov/pubmed/?term=necati%20hakyemez%20i%5bauthor%5d&cauthor=true&cauthor_uid=24353729	https://www.ncbi.nlm.nih.gov/pubmed/?term=necati%20hakyemez%20i%5bauthor%5d&cauthor=true&cauthor_uid=24353729	PROPN
bam-7594	108	48	https://www.ncbi.nlm.nih.gov/pubmed/?term=necati%20hakyemez%20i%5bauthor%5d&cauthor=true&cauthor_uid=24353729	https://www.ncbi.nlm.nih.gov/pubmed/?term=necati%20hakyemez%20i%5bauthor%5d&cauthor=true&cauthor_uid=24353729	PROPN
bam-7594	108	49	https://www.ncbi.nlm.nih.gov/pubmed/?term=necati%20hakyemez%20i%5bauthor%5d&cauthor=true&cauthor_uid=24353729	https://www.ncbi.nlm.nih.gov/pubmed/?term=necati%20hakyemez%20i%5bauthor%5d&cauthor=true&cauthor_uid=24353729	VERB
bam-7594	109	1	https://www.ncbi.nlm.nih.gov/pubmed/?term=vahdani%20p%5bauthor%5d&cauthor=true&cauthor_uid=21811653	https://www.ncbi.nlm.nih.gov/pubmed/?term=vahdani%20p%5bauthor%5d&cauthor=true&cauthor_uid=21811653	X
bam-7594	109	2	antibiotic	antibiotic	ADJ
bam-7594	109	3	resistance	resistance	NOUN
bam-7594	109	4	of	of	ADP
bam-7594	109	5	nosocomial	nosocomial	ADJ
bam-7594	109	6	infections	infection	NOUN
bam-7594	109	7	eur	eur	PROPN
bam-7594	109	8	j	j	PROPN
bam-7594	109	9	transl	transl	PROPN
bam-7594	109	10	myol	myol	ADV
bam-7594	109	11	28	28	NUM
bam-7594	109	12	(	(	PUNCT
bam-7594	109	13	3	3	NUM
bam-7594	109	14	):	):	PUNCT
bam-7594	109	15	304	304	NUM
bam-7594	109	16	-	-	SYM
bam-7594	109	17	308	308	NUM
bam-7594	109	18	,	,	PUNCT
bam-7594	109	19	2018	2018	NUM
bam-7594	109	20	308	308	NUM
bam-7594	109	21	may	may	AUX
bam-7594	109	22	concluded	conclude	VERB
bam-7594	109	23	that	that	SCONJ
bam-7594	109	24	antibiotic	antibiotic	ADJ
bam-7594	109	25	resistance	resistance	NOUN
bam-7594	109	26	is	be	AUX
bam-7594	109	27	increasing	increase	VERB
bam-7594	109	28	in	in	ADP
bam-7594	109	29	nosocomial	nosocomial	ADJ
bam-7594	109	30	infections	infection	NOUN
bam-7594	109	31	in	in	ADP
bam-7594	109	32	our	our	PRON
bam-7594	109	33	hospital	hospital	NOUN
bam-7594	109	34	.	.	PUNCT
bam-7594	110	1	new	new	ADJ
bam-7594	110	2	strategic	strategic	ADJ
bam-7594	110	3	measures	measure	NOUN
bam-7594	110	4	are	be	AUX
bam-7594	110	5	needed	need	VERB
bam-7594	110	6	to	to	PART
bam-7594	110	7	reduce	reduce	VERB
bam-7594	110	8	them	they	PRON
bam-7594	110	9	by	by	ADP
bam-7594	110	10	prevention	prevention	NOUN
bam-7594	110	11	programs	program	NOUN
bam-7594	110	12	.	.	PUNCT
bam-7594	111	1	it	it	PRON
bam-7594	111	2	is	be	AUX
bam-7594	111	3	recommended	recommend	VERB
bam-7594	111	4	that	that	SCONJ
bam-7594	111	5	further	further	ADJ
bam-7594	111	6	studies	study	NOUN
bam-7594	111	7	are	be	AUX
bam-7594	111	8	performed	perform	VERB
bam-7594	111	9	to	to	PART
bam-7594	111	10	confirm	confirm	VERB
bam-7594	111	11	our	our	PRON
bam-7594	111	12	results	result	NOUN
bam-7594	111	13	by	by	ADP
bam-7594	111	14	higher	high	ADJ
bam-7594	111	15	sample	sample	NOUN
bam-7594	111	16	size	size	NOUN
bam-7594	111	17	and	and	CCONJ
bam-7594	111	18	multicenter	multicenter	NOUN
bam-7594	111	19	approch	approch	NOUN
bam-7594	111	20	.	.	PUNCT
bam-7594	112	1	furthermore	furthermore	ADV
bam-7594	112	2	,	,	PUNCT
bam-7594	112	3	investigations	investigation	NOUN
bam-7594	112	4	are	be	AUX
bam-7594	112	5	needed	need	VERB
bam-7594	112	6	on	on	ADP
bam-7594	112	7	the	the	DET
bam-7594	112	8	factors	factor	NOUN
bam-7594	112	9	that	that	PRON
bam-7594	112	10	affect	affect	VERB
bam-7594	112	11	antibiotic	antibiotic	ADJ
bam-7594	112	12	resistance	resistance	NOUN
bam-7594	112	13	.	.	PUNCT
bam-7594	113	1	list	list	NOUN
bam-7594	113	2	of	of	ADP
bam-7594	113	3	acronyms	acronym	NOUN
bam-7594	113	4	uti	uti	PROPN
bam-7594	113	5	urinary	urinary	ADJ
bam-7594	113	6	tract	tract	NOUN
bam-7594	113	7	infection	infection	NOUN
bam-7594	113	8	author	author	NOUN
bam-7594	113	9	’s	’s	PART
bam-7594	113	10	contributions	contribution	NOUN
bam-7594	113	11	authors	author	NOUN
bam-7594	113	12	contributed	contribute	VERB
bam-7594	113	13	equally	equally	ADV
bam-7594	113	14	to	to	ADP
bam-7594	113	15	the	the	DET
bam-7594	113	16	manuscript	manuscript	NOUN
bam-7594	113	17	.	.	PUNCT
bam-7594	114	1	acknowledgments	acknowledgment	NOUN
bam-7594	114	2	funding	funding	NOUN
bam-7594	114	3	:	:	PUNCT
bam-7594	114	4	none	none	NOUN
bam-7594	114	5	.	.	PUNCT
bam-7594	115	1	conflict	conflict	NOUN
bam-7594	115	2	of	of	ADP
bam-7594	115	3	interest	interest	NOUN
bam-7594	115	4	the	the	DET
bam-7594	115	5	authors	author	NOUN
bam-7594	115	6	declare	declare	VERB
bam-7594	115	7	no	no	DET
bam-7594	115	8	conflicts	conflict	NOUN
bam-7594	115	9	of	of	ADP
bam-7594	115	10	interests	interest	NOUN
bam-7594	115	11	.	.	PUNCT
bam-7594	116	1	ethical	ethical	ADJ
bam-7594	116	2	publication	publication	NOUN
bam-7594	116	3	statement	statement	NOUN
bam-7594	116	4	we	we	PRON
bam-7594	116	5	confirm	confirm	VERB
bam-7594	116	6	that	that	SCONJ
bam-7594	116	7	we	we	PRON
bam-7594	116	8	have	have	AUX
bam-7594	116	9	read	read	VERB
bam-7594	116	10	the	the	DET
bam-7594	116	11	journal	journal	NOUN
bam-7594	116	12	’s	’s	PART
bam-7594	116	13	position	position	NOUN
bam-7594	116	14	on	on	ADP
bam-7594	116	15	issues	issue	NOUN
bam-7594	116	16	involved	involve	VERB
bam-7594	116	17	in	in	ADP
bam-7594	116	18	ethical	ethical	ADJ
bam-7594	116	19	publication	publication	NOUN
bam-7594	116	20	and	and	CCONJ
bam-7594	116	21	affirm	affirm	NOUN
bam-7594	116	22	that	that	SCONJ
bam-7594	116	23	this	this	DET
bam-7594	116	24	report	report	NOUN
bam-7594	116	25	is	be	AUX
bam-7594	116	26	consistent	consistent	ADJ
bam-7594	116	27	with	with	ADP
bam-7594	116	28	those	those	DET
bam-7594	116	29	guidelines	guideline	NOUN
bam-7594	116	30	.	.	PUNCT
bam-7594	117	1	corresponding	correspond	VERB
bam-7594	117	2	author	author	PROPN
bam-7594	117	3	ali	ali	PROPN
bam-7594	117	4	asghar	asghar	PROPN
bam-7594	117	5	saeedi	saeedi	PROPN
bam-7594	117	6	,	,	PUNCT
bam-7594	117	7	infectious	infectious	ADJ
bam-7594	117	8	diseases	disease	NOUN
bam-7594	117	9	and	and	CCONJ
bam-7594	117	10	tropical	tropical	ADJ
bam-7594	117	11	medicine	medicine	NOUN
bam-7594	117	12	research	research	NOUN
bam-7594	117	13	center	center	NOUN
bam-7594	117	14	(	(	PUNCT
bam-7594	117	15	idtmrc	idtmrc	NOUN
bam-7594	117	16	)	)	PUNCT
bam-7594	117	17	,	,	PUNCT
bam-7594	117	18	aja	aja	PROPN
bam-7594	117	19	university	university	PROPN
bam-7594	117	20	of	of	ADP
bam-7594	117	21	medical	medical	ADJ
bam-7594	117	22	sciences	sciences	PROPN
bam-7594	117	23	,	,	PUNCT
bam-7594	117	24	tehran	tehran	PROPN
bam-7594	117	25	,	,	PUNCT
bam-7594	117	26	iran	iran	PROPN
bam-7594	117	27	.	.	PUNCT
bam-7594	118	1	phone	phone	NOUN
bam-7594	118	2	+98	+98	PROPN
bam-7594	118	3	9032721145	9032721145	NUM
bam-7594	118	4	email	email	NOUN
bam-7594	118	5	:	:	PUNCT
bam-7594	118	6	dr.saeedi@gmail.com	dr.saeedi@gmail.com	PROPN
bam-7594	118	7	e	e	NOUN
bam-7594	118	8	-	-	NOUN
bam-7594	118	9	mail	mail	NOUN
bam-7594	118	10	of	of	ADP
bam-7594	118	11	co	co	NOUN
bam-7594	118	12	-	-	NOUN
bam-7594	118	13	authors	author	NOUN
bam-7594	118	14	sirous	sirous	ADJ
bam-7594	118	15	faraji	faraji	NOUN
bam-7594	118	16	hormozi	hormozi	NOUN
bam-7594	118	17	:	:	PUNCT
bam-7594	118	18	syrous.faraji@yahoo.com	syrous.faraji@yahoo.com	X
bam-7594	118	19	narges	narge	NOUN
bam-7594	118	20	vasei	vasei	ADJ
bam-7594	118	21	:	:	PUNCT
bam-7594	118	22	nvasei@yahoo.com	nvasei@yahoo.com	X
bam-7594	118	23	mohammad	mohammad	PROPN
bam-7594	118	24	aminianfar	aminianfar	ADV
bam-7594	118	25	:	:	PUNCT
bam-7594	118	26	maminianfar@yahoo.com	maminianfar@yahoo.com	PROPN
bam-7594	118	27	mohammad	mohammad	PROPN
bam-7594	118	28	darvishi	darvishi	PROPN
bam-7594	118	29	:	:	PUNCT
bam-7594	118	30	darvishi1349@gmail.com	darvishi1349@gmail.com	X
bam-7594	119	1	references	reference	NOUN
bam-7594	119	2	1	1	NUM
bam-7594	119	3	.	.	PUNCT
bam-7594	119	4	faraji	faraji	PROPN
bam-7594	119	5	hormozi	hormozi	PROPN
bam-7594	119	6	s	s	PROPN
bam-7594	119	7	,	,	PUNCT
bam-7594	119	8	saeedi	saeedi	VERB
bam-7594	119	9	aa	aa	NOUN
bam-7594	119	10	,	,	PUNCT
bam-7594	119	11	aminianfar	aminianfar	ADV
bam-7594	119	12	m	m	PROPN
bam-7594	119	13	,	,	PUNCT
bam-7594	119	14	salmani	salmani	PROPN
bam-7594	119	15	alishah	alishah	PROPN
bam-7594	119	16	m	m	PROPN
bam-7594	119	17	,	,	PUNCT
bam-7594	119	18	darvishi	darvishi	ADJ
bam-7594	119	19	m.	m.	NOUN
bam-7594	119	20	studying	study	VERB
bam-7594	119	21	the	the	DET
bam-7594	119	22	frequency	frequency	NOUN
bam-7594	119	23	of	of	ADP
bam-7594	119	24	nosocomial	nosocomial	ADJ
bam-7594	119	25	infection	infection	NOUN
bam-7594	119	26	and	and	CCONJ
bam-7594	119	27	its	its	PRON
bam-7594	119	28	relative	relative	ADJ
bam-7594	119	29	factors	factor	NOUN
bam-7594	119	30	in	in	ADP
bam-7594	119	31	the	the	DET
bam-7594	119	32	intensive	intensive	ADJ
bam-7594	119	33	care	care	NOUN
bam-7594	119	34	unit	unit	NOUN
bam-7594	119	35	of	of	ADP
bam-7594	119	36	hospitals	hospital	NOUN
bam-7594	119	37	based	base	VERB
bam-7594	119	38	upon	upon	SCONJ
bam-7594	119	39	nni	nni	PROPN
bam-7594	119	40	system	system	PROPN
bam-7594	119	41	.	.	PUNCT
bam-7594	120	1	eurasian	eurasian	PROPN
bam-7594	120	2	j	j	PROPN
bam-7594	120	3	anal	anal	ADJ
bam-7594	120	4	chem	chem	NOUN
bam-7594	120	5	2018;13	2018;13	NOUN
bam-7594	120	6	:	:	PUNCT
bam-7594	120	7	em16	em16	PROPN
bam-7594	120	8	.	.	PUNCT
bam-7594	121	1	2	2	NUM
bam-7594	121	2	.	.	X
bam-7594	121	3	ak	ak	PROPN
bam-7594	121	4	o	o	PROPN
bam-7594	121	5	,	,	PUNCT
bam-7594	121	6	batirel	batirel	PROPN
bam-7594	121	7	a	a	NOUN
bam-7594	121	8	,	,	PUNCT
bam-7594	121	9	ozer	ozer	PROPN
bam-7594	121	10	s	s	PROPN
bam-7594	121	11	,	,	PUNCT
bam-7594	121	12	çolakoglu	çolakoglu	ADJ
bam-7594	121	13	s.	s.	PROPN
bam-7594	121	14	nosocomial	nosocomial	ADJ
bam-7594	121	15	infections	infection	NOUN
bam-7594	121	16	and	and	CCONJ
bam-7594	121	17	risk	risk	NOUN
bam-7594	121	18	factors	factor	NOUN
bam-7594	121	19	in	in	ADP
bam-7594	121	20	the	the	DET
bam-7594	121	21	intensive	intensive	ADJ
bam-7594	121	22	care	care	NOUN
bam-7594	121	23	unit	unit	NOUN
bam-7594	121	24	of	of	ADP
bam-7594	121	25	a	a	DET
bam-7594	121	26	teaching	teaching	NOUN
bam-7594	121	27	and	and	CCONJ
bam-7594	121	28	research	research	NOUN
bam-7594	121	29	hospital	hospital	NOUN
bam-7594	121	30	:	:	PUNCT
bam-7594	121	31	a	a	DET
bam-7594	121	32	prospective	prospective	ADJ
bam-7594	121	33	cohort	cohort	NOUN
bam-7594	121	34	study	study	NOUN
bam-7594	121	35	.	.	PUNCT
bam-7594	122	1	med	med	PROPN
bam-7594	122	2	sci	sci	PROPN
bam-7594	122	3	monit	monit	PROPN
bam-7594	122	4	2011;17:29	2011;17:29	NUM
bam-7594	122	5	-	-	SYM
bam-7594	122	6	34	34	NUM
bam-7594	122	7	.	.	NOUN
bam-7594	123	1	3	3	NUM
bam-7594	123	2	.	.	X
bam-7594	123	3	darvishi	darvishi	ADJ
bam-7594	123	4	m.	m.	NOUN
bam-7594	123	5	antibiotic	antibiotic	ADJ
bam-7594	123	6	resistance	resistance	NOUN
bam-7594	123	7	pattern	pattern	NOUN
bam-7594	123	8	of	of	ADP
bam-7594	123	9	uropathogenic	uropathogenic	ADJ
bam-7594	123	10	methicillin	methicillin	NOUN
bam-7594	123	11	resistant	resistant	ADJ
bam-7594	123	12	staphylococcus	staphylococcus	NOUN
bam-7594	123	13	aureus	aureus	NOUN
bam-7594	123	14	isolated	isolate	VERB
bam-7594	123	15	from	from	ADP
bam-7594	123	16	immunosuppressive	immunosuppressive	ADJ
bam-7594	123	17	patients	patient	NOUN
bam-7594	123	18	with	with	ADP
bam-7594	123	19	pyelonephritis	pyelonephritis	PROPN
bam-7594	123	20	.	.	PUNCT
bam-7594	124	1	j	j	PROPN
bam-7594	124	2	pure	pure	ADJ
bam-7594	124	3	apple	apple	NOUN
bam-7594	124	4	microbe	microbe	NOUN
bam-7594	124	5	2016;10:2663	2016;10:2663	NOUN
bam-7594	124	6	-	-	SYM
bam-7594	124	7	667	667	NUM
bam-7594	124	8	.	.	PUNCT
bam-7594	125	1	4	4	NUM
bam-7594	125	2	.	.	X
bam-7594	125	3	richards	richards	PROPN
bam-7594	125	4	mj	mj	PROPN
bam-7594	125	5	,	,	PUNCT
bam-7594	125	6	edwards	edwards	PROPN
bam-7594	125	7	jr	jr	PROPN
bam-7594	125	8	,	,	PUNCT
bam-7594	125	9	culver	culver	PROPN
bam-7594	125	10	dh	dh	PROPN
bam-7594	125	11	,	,	PUNCT
bam-7594	125	12	gaynes	gayne	VERB
bam-7594	125	13	rp	rp	NOUN
bam-7594	125	14	.	.	PUNCT
bam-7594	126	1	nosocomial	nosocomial	ADJ
bam-7594	126	2	infections	infection	NOUN
bam-7594	126	3	in	in	ADP
bam-7594	126	4	medical	medical	ADJ
bam-7594	126	5	intensive	intensive	ADJ
bam-7594	126	6	care	care	NOUN
bam-7594	126	7	units	unit	NOUN
bam-7594	126	8	in	in	ADP
bam-7594	126	9	the	the	DET
bam-7594	126	10	united	united	PROPN
bam-7594	126	11	states	states	PROPN
bam-7594	126	12	.	.	PUNCT
bam-7594	127	1	national	national	ADJ
bam-7594	127	2	nosocomial	nosocomial	ADJ
bam-7594	127	3	infections	infection	NOUN
bam-7594	127	4	surveillance	surveillance	NOUN
bam-7594	127	5	system	system	NOUN
bam-7594	127	6	.	.	PUNCT
bam-7594	128	1	crit	crit	PROPN
bam-7594	128	2	care	care	PROPN
bam-7594	128	3	med	med	ADJ
bam-7594	128	4	1999;27:887	1999;27:887	NUM
bam-7594	128	5	-	-	SYM
bam-7594	128	6	92	92	NUM
bam-7594	128	7	.	.	PUNCT
bam-7594	129	1	5	5	NUM
bam-7594	129	2	.	.	X
bam-7594	129	3	manzoni	manzoni	PROPN
bam-7594	129	4	p	p	X
bam-7594	129	5	,	,	PUNCT
bam-7594	129	6	de	de	X
bam-7594	129	7	luca	luca	PROPN
bam-7594	129	8	d	d	PROPN
bam-7594	129	9	,	,	PUNCT
bam-7594	129	10	stronati	stronati	PROPN
bam-7594	129	11	m	m	PROPN
bam-7594	129	12	,	,	PUNCT
bam-7594	129	13	et	et	PROPN
bam-7594	129	14	al	al	PROPN
bam-7594	129	15	.	.	PROPN
bam-7594	129	16	prevention	prevention	NOUN
bam-7594	129	17	of	of	ADP
bam-7594	129	18	nosocomial	nosocomial	ADJ
bam-7594	129	19	infections	infection	NOUN
bam-7594	129	20	in	in	ADP
bam-7594	129	21	neonatal	neonatal	ADJ
bam-7594	129	22	intensive	intensive	ADJ
bam-7594	129	23	care	care	NOUN
bam-7594	129	24	units	unit	NOUN
bam-7594	129	25	.	.	PUNCT
bam-7594	130	1	am	be	AUX
bam-7594	130	2	j	j	PROPN
bam-7594	130	3	perinatol	perinatol	NOUN
bam-7594	130	4	2013;30:81	2013;30:81	NUM
bam-7594	130	5	-	-	SYM
bam-7594	130	6	8	8	NUM
bam-7594	130	7	.	.	NOUN
bam-7594	131	1	6	6	NUM
bam-7594	131	2	.	.	NOUN
bam-7594	131	3	emori	emori	PROPN
bam-7594	131	4	tg	tg	PROPN
bam-7594	131	5	,	,	PUNCT
bam-7594	131	6	gaynes	gayne	VERB
bam-7594	131	7	rp	rp	NOUN
bam-7594	131	8	.	.	PUNCT
bam-7594	132	1	an	an	DET
bam-7594	132	2	overview	overview	NOUN
bam-7594	132	3	of	of	ADP
bam-7594	132	4	nosocomial	nosocomial	ADJ
bam-7594	132	5	infections	infection	NOUN
bam-7594	132	6	,	,	PUNCT
bam-7594	132	7	including	include	VERB
bam-7594	132	8	the	the	DET
bam-7594	132	9	role	role	NOUN
bam-7594	132	10	of	of	ADP
bam-7594	132	11	the	the	DET
bam-7594	132	12	microbiology	microbiology	NOUN
bam-7594	132	13	laboratory	laboratory	NOUN
bam-7594	132	14	.	.	PUNCT
bam-7594	133	1	clin	clin	PROPN
bam-7594	133	2	microbiol	microbiol	PROPN
bam-7594	133	3	rev	rev	VERB
bam-7594	133	4	1993;6:428	1993;6:428	PROPN
bam-7594	133	5	-	-	SYM
bam-7594	133	6	42	42	NUM
bam-7594	133	7	.	.	PUNCT
bam-7594	134	1	7	7	X
bam-7594	134	2	.	.	PUNCT
bam-7594	134	3	behzadnia	behzadnia	PROPN
bam-7594	134	4	s	s	PROPN
bam-7594	134	5	,	,	PUNCT
bam-7594	134	6	davoudi	davoudi	PROPN
bam-7594	134	7	a	a	X
bam-7594	134	8	,	,	PUNCT
bam-7594	134	9	rezai	rezai	ADJ
bam-7594	134	10	ms	ms	PROPN
bam-7594	134	11	,	,	PUNCT
bam-7594	134	12	ahangarkani	ahangarkani	PROPN
bam-7594	134	13	f.	f.	PROPN
bam-7594	134	14	nosocomial	nosocomial	ADJ
bam-7594	134	15	infections	infection	NOUN
bam-7594	134	16	in	in	ADP
bam-7594	134	17	pediatric	pediatric	ADJ
bam-7594	134	18	population	population	NOUN
bam-7594	134	19	and	and	CCONJ
bam-7594	134	20	antibiotic	antibiotic	ADJ
bam-7594	134	21	resistance	resistance	NOUN
bam-7594	134	22	of	of	ADP
bam-7594	134	23	the	the	DET
bam-7594	134	24	causative	causative	ADJ
bam-7594	134	25	organisms	organism	NOUN
bam-7594	134	26	in	in	ADP
bam-7594	134	27	north	north	NOUN
bam-7594	134	28	of	of	ADP
bam-7594	134	29	iran	iran	PROPN
bam-7594	134	30	.	.	PUNCT
bam-7594	135	1	iran	iran	PROPN
bam-7594	135	2	red	red	PROPN
bam-7594	135	3	crescent	crescent	PROPN
bam-7594	135	4	med	med	PROPN
bam-7594	136	1	j	j	PROPN
bam-7594	136	2	2014;16	2014;16	NUM
bam-7594	136	3	:	:	PUNCT
bam-7594	136	4	e14562	e14562	ADJ
bam-7594	136	5	.	.	NOUN
bam-7594	136	6	8	8	NUM
bam-7594	136	7	.	.	X
bam-7594	137	1	necati	necati	PROPN
bam-7594	137	2	hakyemez	hakyemez	PROPN
bam-7594	138	1	i	i	PROPN
bam-7594	138	2	,	,	PUNCT
bam-7594	138	3	kucukbayrak	kucukbayrak	PROPN
bam-7594	138	4	a	a	PROPN
bam-7594	138	5	,	,	PUNCT
bam-7594	138	6	tas	tas	PROPN
bam-7594	138	7	t	t	PROPN
bam-7594	138	8	,	,	PUNCT
bam-7594	138	9	et	et	PROPN
bam-7594	138	10	al	al	PROPN
bam-7594	138	11	.	.	PUNCT
bam-7594	138	12	nosocomial	nosocomial	ADJ
bam-7594	138	13	acinetobacter	acinetobacter	ADJ
bam-7594	138	14	baumannii	baumannii	ADJ
bam-7594	138	15	infections	infection	NOUN
bam-7594	138	16	and	and	CCONJ
bam-7594	138	17	changing	change	VERB
bam-7594	138	18	antibiotic	antibiotic	ADJ
bam-7594	138	19	resistance	resistance	NOUN
bam-7594	138	20	.	.	PUNCT
bam-7594	139	1	pak	pak	PROPN
bam-7594	139	2	j	j	PROPN
bam-7594	139	3	med	med	PROPN
bam-7594	139	4	sci	sci	PROPN
bam-7594	139	5	2013;29:1245	2013;29:1245	PROPN
bam-7594	139	6	-	-	SYM
bam-7594	139	7	8	8	NUM
bam-7594	139	8	.	.	NOUN
bam-7594	139	9	9	9	NUM
bam-7594	139	10	.	.	X
bam-7594	139	11	vahdani	vahdani	PROPN
bam-7594	139	12	p	p	NOUN
bam-7594	139	13	,	,	PUNCT
bam-7594	139	14	yaghoubi	yaghoubi	NOUN
bam-7594	139	15	t	t	PROPN
bam-7594	139	16	,	,	PUNCT
bam-7594	139	17	aminzadeh	aminzadeh	PROPN
bam-7594	139	18	z.	z.	PROPN
bam-7594	139	19	hospital	hospital	PROPN
bam-7594	139	20	acquired	acquire	VERB
bam-7594	139	21	antibiotic	antibiotic	ADJ
bam-7594	139	22	-	-	PUNCT
bam-7594	139	23	resistant	resistant	ADJ
bam-7594	139	24	acinetobacter	acinetobacter	ADJ
bam-7594	139	25	baumannii	baumannii	ADJ
bam-7594	139	26	infections	infection	NOUN
bam-7594	139	27	in	in	ADP
bam-7594	139	28	a	a	DET
bam-7594	139	29	400	400	NUM
bam-7594	139	30	-	-	PUNCT
bam-7594	139	31	bed	bed	NOUN
bam-7594	139	32	hospital	hospital	NOUN
bam-7594	139	33	in	in	ADP
bam-7594	139	34	tehran	tehran	PROPN
bam-7594	139	35	,	,	PUNCT
bam-7594	139	36	iran	iran	PROPN
bam-7594	139	37	.	.	PUNCT
bam-7594	140	1	int	int	PROPN
bam-7594	140	2	j	j	PROPN
bam-7594	140	3	prev	prev	X
bam-7594	140	4	med	med	PROPN
bam-7594	140	5	2011;2:127	2011;2:127	NUM
bam-7594	140	6	-	-	SYM
bam-7594	140	7	30	30	NUM
bam-7594	140	8	.	.	PUNCT
bam-7594	140	9	10	10	NUM
bam-7594	140	10	.	.	PUNCT
bam-7594	141	1	ahmed	ahmed	PROPN
bam-7594	141	2	sh	sh	PROPN
bam-7594	141	3	,	,	PUNCT
bam-7594	141	4	daef	daef	NOUN
bam-7594	141	5	ea	ea	PROPN
bam-7594	141	6	,	,	PUNCT
bam-7594	141	7	badary	badary	ADJ
bam-7594	141	8	ms	ms	PROPN
bam-7594	141	9	,	,	PUNCT
bam-7594	141	10	mahmoud	mahmoud	PROPN
bam-7594	141	11	ma	ma	PROPN
bam-7594	141	12	,	,	PUNCT
bam-7594	141	13	abd	abd	PROPN
bam-7594	141	14	-	-	PUNCT
bam-7594	141	15	elsayed	elsaye	VERB
bam-7594	141	16	aa	aa	NOUN
bam-7594	141	17	.	.	PUNCT
bam-7594	142	1	nosocomial	nosocomial	ADJ
bam-7594	142	2	blood	blood	NOUN
bam-7594	142	3	stream	stream	NOUN
bam-7594	142	4	infection	infection	NOUN
bam-7594	142	5	in	in	ADP
bam-7594	142	6	intensive	intensive	ADJ
bam-7594	142	7	care	care	NOUN
bam-7594	142	8	units	unit	NOUN
bam-7594	142	9	at	at	ADP
bam-7594	142	10	assiut	assiut	NOUN
bam-7594	142	11	university	university	NOUN
bam-7594	142	12	hospitals	hospital	NOUN
bam-7594	142	13	(	(	PUNCT
bam-7594	142	14	upper	upper	ADJ
bam-7594	142	15	egypt	egypt	PROPN
bam-7594	142	16	)	)	PUNCT
bam-7594	142	17	with	with	ADP
bam-7594	142	18	special	special	ADJ
bam-7594	142	19	reference	reference	NOUN
bam-7594	142	20	to	to	ADP
bam-7594	142	21	extended	extended	ADJ
bam-7594	142	22	spectrum	spectrum	NOUN
bam-7594	142	23	beta	beta	NOUN
bam-7594	142	24	-	-	PUNCT
bam-7594	142	25	lactamase	lactamase	NOUN
bam-7594	142	26	producing	produce	VERB
bam-7594	142	27	organisms	organism	NOUN
bam-7594	142	28	.	.	PUNCT
bam-7594	143	1	bmc	bmc	ADJ
bam-7594	143	2	res	re	NOUN
bam-7594	143	3	notes	note	NOUN
bam-7594	143	4	2009;2:76	2009;2:76	NOUN
bam-7594	143	5	.	.	PUNCT
bam-7594	144	1	11	11	NUM
bam-7594	144	2	.	.	PUNCT
bam-7594	144	3	weinstein	weinstein	PROPN
bam-7594	144	4	ra	ra	PROPN
bam-7594	144	5	.	.	PUNCT
bam-7594	145	1	controlling	control	VERB
bam-7594	145	2	antimicrobial	antimicrobial	ADJ
bam-7594	145	3	resistance	resistance	NOUN
bam-7594	145	4	in	in	ADP
bam-7594	145	5	hospitals	hospital	NOUN
bam-7594	145	6	:	:	PUNCT
bam-7594	145	7	infection	infection	NOUN
bam-7594	145	8	control	control	NOUN
bam-7594	145	9	and	and	CCONJ
bam-7594	145	10	use	use	NOUN
bam-7594	145	11	of	of	ADP
bam-7594	145	12	antibiotics	antibiotic	NOUN
bam-7594	145	13	.	.	PUNCT
bam-7594	146	1	emerg	emerg	PROPN
bam-7594	146	2	infect	infect	ADJ
bam-7594	146	3	dis	dis	PROPN
bam-7594	146	4	2001;7:188	2001;7:188	NUM
bam-7594	146	5	-	-	SYM
bam-7594	146	6	92	92	NUM
bam-7594	146	7	.	.	PUNCT
bam-7594	147	1	submission	submission	NOUN
bam-7594	147	2	:	:	PUNCT
bam-7594	147	3	june	june	PROPN
bam-7594	147	4	5	5	NUM
bam-7594	147	5	,	,	PUNCT
bam-7594	147	6	2018	2018	NUM
bam-7594	147	7	revision	revision	NOUN
bam-7594	147	8	received	receive	VERB
bam-7594	147	9	:	:	PUNCT
bam-7594	147	10	june	june	PROPN
bam-7594	147	11	14	14	NUM
bam-7594	147	12	,	,	PUNCT
bam-7594	147	13	2018	2018	NUM
bam-7594	147	14	acceptance	acceptance	NOUN
bam-7594	147	15	:	:	PUNCT
bam-7594	147	16	june	june	PROPN
bam-7594	147	17	14	14	NUM
bam-7594	147	18	,	,	PUNCT
bam-7594	147	19	2018	2018	NUM
bam-7594	147	20	non	non	X
bam-7594	147	21	co	co	X
bam-7594	147	22	mmerc	mmerc	PROPN
bam-7594	147	23	ial	ial	PROPN
bam-7594	147	24	us	us	PROPN
bam-7594	148	1	e	e	NOUN
bam-7594	148	2	o	o	PROPN
bam-7594	148	3	nly	nly	ADV
bam-7594	148	4	mailto:dr.saeedi@gmail.com	mailto:dr.saeedi@gmail.com	PROPN
bam-7594	148	5	mailto:syrous.faraji@yahoo.com	mailto:syrous.faraji@yahoo.com	PROPN
bam-7594	148	6	mailto:nvasei@yahoo.com	mailto:nvasei@yahoo.com	X
bam-7594	148	7	mailto:maminianfar@yahoo.com	mailto:maminianfar@yahoo.com	PROPN
bam-7594	148	8	mailto:darvishi1349@gmail.com	mailto:darvishi1349@gmail.com	PROPN